| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ephrin receptor activity | 7.14e-07 | 19 | 187 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.49e-06 | 65 | 187 | 7 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 9.38e-06 | 15 | 187 | 4 | GO:0005005 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.51e-05 | 85 | 187 | 7 | GO:0019199 | |
| GeneOntologyMolecularFunction | peptide binding | EPHB2 HLA-C HLA-G IDE PPARG ADCYAP1R1 CLTC CST4 CST5 LRP1 PEX5 MME | 4.81e-05 | 318 | 187 | 12 | GO:0042277 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 6.80e-05 | 145 | 187 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 1.67e-04 | 12 | 187 | 3 | GO:0003953 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 2.60e-04 | 3 | 187 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | soluble NSF attachment protein activity | 2.60e-04 | 3 | 187 | 2 | GO:0005483 | |
| GeneOntologyMolecularFunction | histone H3K27 trimethyltransferase activity | 2.60e-04 | 3 | 187 | 2 | GO:0140951 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D19 DOCK1 SGSM1 ARHGAP39 ALS2CL ARHGAP1 ARHGAP25 GNAQ ARHGAP8 ARHGAP21 | 3.11e-04 | 279 | 187 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | cadherin binding | ABI1 PSEN1 OLFM4 RDX ARHGAP1 P2RX4 ANLN EPHA2 TJP2 HCFC1 PHLDB2 | 3.67e-04 | 339 | 187 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 4.14e-04 | 16 | 187 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG ABI1 PSEN1 DSCAM OLFM4 RDX ITGA3 ARHGAP1 P2RX4 TENM3 ANLN EPHA2 TJP2 HCFC1 PHLDB2 | 5.37e-04 | 599 | 187 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.55e-04 | 44 | 187 | 4 | GO:0140938 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB2 ADCY10 PRTG PSEN1 DSCAM SLITRK4 PPARG EZH2 TF DICER1 GH2 IL1RAPL1 SLITRK2 PPP3CA PRMT5 LRP1 LRP4 MME IL1RAP MUSK EPHA7 | 2.87e-07 | 625 | 188 | 21 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TBC1D19 EPHB2 DOCK1 ABCB7 INPP5K SLITRK4 DYRK1A NAPA RDX PYDC1 KAT2A PPARG HNRNPU IL1RAPL1 KAT2B SLITRK2 P2RX4 NAPB IL1RAPL2 ANLN EPHA2 VPS41 LRP1 PEX5 LRP4 IL1RAP HCFC1 MUSK PHLDB2 EPHA7 | 3.78e-07 | 1189 | 188 | 30 | GO:0044087 |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 4.55e-07 | 8 | 188 | 4 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TBC1D19 EPHB2 ADCY10 PSEN1 DSCAM HLA-C HLA-G RDX KAT2A ITGA3 INPP5F EZH2 IL1RAPL1 KAT2B PPP3CA P2RX4 TENM3 ANLN EPHA2 LRP1 LRP4 MUSK EPHA7 | 4.08e-06 | 863 | 188 | 23 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | EPHB2 ADCY10 PRTG PSEN1 DSCAM PPARG EZH2 TF DICER1 GH2 IL1RAPL1 PPP3CA PRMT5 LRP1 LRP4 MME EPHA7 | 5.24e-06 | 515 | 188 | 17 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | EPHB2 DOCK1 SLITRK4 IL1RAPL1 SLITRK2 IL1RAPL2 EPHA2 LRP1 LRP4 IL1RAP MUSK PHLDB2 EPHA7 | 5.50e-06 | 309 | 188 | 13 | GO:1901888 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | EPHB2 ADCY10 DSCAM SLITRK4 PPARG TF DICER1 GH2 IL1RAPL1 SLITRK2 PRMT5 LRP1 MME IL1RAP MUSK | 7.16e-06 | 418 | 188 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | response to tetrachloromethane | 7.35e-06 | 5 | 188 | 3 | GO:1904772 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TBC1D19 EPHB2 ADCY10 PSEN1 DSCAM HLA-C HLA-G RDX ITGA3 INPP5F EZH2 IL1RAPL1 KAT2B PPP3CA P2RX4 TENM3 ANLN EPHA2 LRP1 LRP4 MUSK EPHA7 | 9.87e-06 | 846 | 188 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | ERAD pathway | 1.36e-05 | 119 | 188 | 8 | GO:0036503 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | EPHB2 PSEN1 HLA-C INPP5K HLA-G DYRK1A RDX PYDC1 KAT2A ITGA3 INPP5F PPARG HNRNPU KAT2B PPP3CA CST4 CST5 LRP1 PEX5 LRP4 PHLDB2 EPHA7 | 1.37e-05 | 864 | 188 | 22 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | EPHB2 ADCY10 PSEN1 INPP5K SLC26A4 TOR1A RDX FIS1 ITGA3 INPP5F PPARG ADCYAP1R1 ARHGAP1 PPP3CA P2RX4 CSNK2A1 EPHA2 CLTC LRP1 LRP4 GNAO1 GNAQ ARHGAP8 AKAP1 HCFC1 MUSK EPHA5 | 1.53e-05 | 1212 | 188 | 27 | GO:0060341 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | EPHB2 DOCK1 SLITRK4 IL1RAPL1 SLITRK2 IL1RAPL2 LRP4 IL1RAP MUSK EPHA7 | 1.71e-05 | 202 | 188 | 10 | GO:0051963 |
| GeneOntologyBiologicalProcess | presynapse assembly | 1.76e-05 | 60 | 188 | 6 | GO:0099054 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | PIWIL1 DYRK1A PIWIL2 EZH1 EZH2 SUV39H2 DICER1 HNRNPU WDHD1 PRMT5 | 1.78e-05 | 203 | 188 | 10 | GO:0045814 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 ADCY10 RPGRIP1 PRTG ABI1 PSEN1 DSCAM HLA-C SLITRK4 HLA-G TOR1A APLP2 ITGA3 INPP5F EZH2 DICER1 SCYL2 IL1RAPL1 KAT2B SLITRK2 PPP3CA TENM3 PJVK LRP1 LRP4 GNAQ MUSK EPHA10 EPHA5 EPHA7 | 2.40e-05 | 1463 | 188 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 3.03e-05 | 40 | 188 | 5 | GO:0097242 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | ATRN PSEN1 PSMB5 GPX5 TOR1A IDE HAO1 EZH2 ADCYAP1R1 GSTP1 KAT2B PJVK CST4 CST5 PEX5 | 3.44e-05 | 478 | 188 | 15 | GO:0006979 |
| GeneOntologyBiologicalProcess | regulation of presynapse assembly | 3.86e-05 | 42 | 188 | 5 | GO:1905606 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 3.86e-05 | 42 | 188 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 4.04e-05 | 8 | 188 | 3 | GO:1902425 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 ADCY10 PRTG ABI1 PSEN1 DSCAM HLA-C SLITRK4 HLA-G TOR1A APLP2 ITGA3 INPP5F EZH2 DICER1 IL1RAPL1 KAT2B SLITRK2 PPP3CA TENM3 PJVK LRP1 LRP4 MUSK EPHA10 EPHA5 EPHA7 | 4.25e-05 | 1285 | 188 | 27 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB2 ADCY10 PSEN1 DSCAM HLA-C HLA-G ITGA3 INPP5F EZH2 IL1RAPL1 KAT2B PPP3CA TENM3 LRP1 LRP4 MUSK EPHA7 | 4.77e-05 | 612 | 188 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 4.86e-05 | 142 | 188 | 8 | GO:0003300 | |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | EPHB2 PSEN1 INPP5K CD109 RDX PPARG SERPINH1 HNRNPU GSTP1 KAT2B CSNK2A1 CST4 CST5 LAMP3 LRP1 GNAI2 GNAQ | 5.06e-05 | 615 | 188 | 17 | GO:0043086 |
| GeneOntologyBiologicalProcess | presynapse organization | 5.43e-05 | 73 | 188 | 6 | GO:0099172 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 5.76e-05 | 233 | 188 | 10 | GO:0031345 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 5.92e-05 | 146 | 188 | 8 | GO:0014897 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 6.04e-05 | 46 | 188 | 5 | GO:0099174 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 6.52e-05 | 148 | 188 | 8 | GO:0014896 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 6.64e-05 | 237 | 188 | 10 | GO:1905475 | |
| GeneOntologyBiologicalProcess | protein catabolic process | SEL1L PSMF1 KAT5 PSEN1 SGTA PSMB5 TOR1A RDX RNF213 IDE EDEM3 PJA2 ERLIN2 CSNK2A1 CST4 CST5 LAMP3 LRP1 UGGT2 SEL1L2 MME UBE3C CSNK2A3 RCN3 | 8.14e-05 | 1115 | 188 | 24 | GO:0030163 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 DOCK1 PSEN1 DSCAM SLITRK4 RDX ARHGAP39 ITGA3 IL1RAPL1 GRHL1 SLITRK2 TENM3 IL1RAPL2 EPHA2 LRP1 TJP2 LRP4 IL1RAP MUSK PHLDB2 EPHA5 EPHA7 | 8.25e-05 | 974 | 188 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | hepatocyte homeostasis | 8.26e-05 | 2 | 188 | 2 | GO:0036333 | |
| GeneOntologyBiologicalProcess | negative regulation of endocytic recycling | 8.26e-05 | 2 | 188 | 2 | GO:2001136 | |
| GeneOntologyBiologicalProcess | regulation of attachment of mitotic spindle microtubules to kinetochore | 8.53e-05 | 10 | 188 | 3 | GO:1902423 | |
| GeneOntologyBiologicalProcess | response to endoplasmic reticulum stress | SEL1L NIBAN1 SGTA TOR1A FIS1 PDIA3 EDEM3 ERLIN2 UGGT2 SEL1L2 RCN3 | 8.74e-05 | 295 | 188 | 11 | GO:0034976 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SEL1L EPHB2 BRIP1 PSEN1 SGTA INPP5K TOR1A HMGCS2 IDE PPARG EZH2 STAT4 GH2 EDEM3 KAT2B ERLIN2 PPP3CA P2RX4 PRMT5 LRP1 UGGT2 GNAI2 SEL1L2 GNAO1 GNAQ RCN3 | 9.39e-05 | 1272 | 188 | 26 | GO:1901698 |
| GeneOntologyBiologicalProcess | circadian rhythm | KAT5 DYRK1A PIWIL2 PPARG EZH2 SUV39H2 HNRNPU PRMT5 ZFHX3 GNAQ | 9.68e-05 | 248 | 188 | 10 | GO:0007623 |
| GeneOntologyBiologicalProcess | attachment of mitotic spindle microtubules to kinetochore | 9.96e-05 | 27 | 188 | 4 | GO:0051315 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 1.17e-04 | 11 | 188 | 3 | GO:0099545 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPHB2 ADCY10 ABCB7 KAT5 PSEN1 DSCAM SLITRK4 TOR1A FIS1 PIWIL2 KAT2A ITGA3 PPARG EZH2 TF IL1RAPL1 KAT2B SLITRK2 PPP3CA TENM3 ANLN EPHA2 LRP1 LRP4 IL1RAP MUSK PHLDB2 | 1.19e-04 | 1366 | 188 | 27 | GO:0051130 |
| GeneOntologyBiologicalProcess | rhythmic process | KAT5 DYRK1A PIWIL2 PPARG EZH2 SUV39H2 HNRNPU KAT2B CSNK2A1 PRMT5 ZFHX3 GNAQ | 1.21e-04 | 360 | 188 | 12 | GO:0048511 |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB2 DOCK1 DSCAM SLITRK4 IL1RAPL1 SLITRK2 IL1RAPL2 LRP4 IL1RAP MUSK EPHA7 | 1.28e-04 | 308 | 188 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | heterochromatin formation | 1.28e-04 | 163 | 188 | 8 | GO:0031507 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.31e-04 | 54 | 188 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 1.36e-04 | 86 | 188 | 6 | GO:0051965 | |
| GeneOntologyBiologicalProcess | postsynapse organization | EPHB2 DOCK1 PSEN1 ARHGAP39 ITGA3 IL1RAPL1 LRP4 IL1RAP MUSK EPHA5 EPHA7 | 1.47e-04 | 313 | 188 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of attachment of spindle microtubules to kinetochore | 1.54e-04 | 12 | 188 | 3 | GO:0051987 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.64e-04 | 169 | 188 | 8 | GO:0010977 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 1.92e-04 | 130 | 188 | 7 | GO:1905477 | |
| GeneOntologyBiologicalProcess | constitutive heterochromatin formation | 1.99e-04 | 13 | 188 | 3 | GO:0140719 | |
| GeneOntologyBiologicalProcess | chondrocyte development involved in endochondral bone morphogenesis | 1.99e-04 | 13 | 188 | 3 | GO:0003433 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis | PSMF1 PSEN1 SGTA CD109 IDE SERPINH1 CSNK2A1 CST4 CST5 LAMP3 LRP1 | 2.10e-04 | 326 | 188 | 11 | GO:0045861 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | EPHB2 ADCY10 NIBAN1 ABI1 PSEN1 DSCAM INPP5K CD109 APLP2 FIS1 INPP5F PPARG EZH2 TF DICER1 ADCYAP1R1 HNRNPU GH2 GSTP1 KAT2B EPHA2 LRP4 GNAQ AKAP1 MUSK EPHA5 EPHA7 | 2.26e-04 | 1421 | 188 | 27 | GO:0019220 |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | SEL1L PSMF1 KAT5 PSEN1 SGTA PSMB5 TOR1A EDEM3 PJA2 ERLIN2 CSNK2A1 LAMP3 UGGT2 SEL1L2 RCN3 | 2.28e-04 | 567 | 188 | 15 | GO:0010498 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | EPHB2 ADCY10 NIBAN1 ABI1 PSEN1 DSCAM INPP5K CD109 APLP2 FIS1 INPP5F PPARG EZH2 TF DICER1 ADCYAP1R1 HNRNPU GH2 GSTP1 KAT2B EPHA2 LRP4 GNAQ AKAP1 MUSK EPHA5 EPHA7 | 2.31e-04 | 1423 | 188 | 27 | GO:0051174 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | PIWIL1 DYRK1A PIWIL2 EZH1 EZH2 SUV39H2 DICER1 HNRNPU KAT2B WDHD1 PRMT5 | 2.33e-04 | 330 | 188 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | synaptic signaling | EPHB2 ABI1 PSEN1 TOR1A NAPA GRIK1 KAT2A EZH2 IL1RAPL1 PPP3CA P2RX4 NAPB STON2 DNAJC5 GNAI2 MME GNAO1 GNAQ IL1RAP MUSK EPHA7 | 2.35e-04 | 976 | 188 | 21 | GO:0099536 |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB2 ATRN NR2C2 CLUAP1 PSEN1 DSCAM NAPA APLP2 GRIK1 KAT2A PPARG EZH1 EZH2 DICER1 SCYL2 GSTP1 IL1RAPL2 PRMT5 LRP1 PEX5 GNAQ DNAH5 EPHA5 EPHA7 | 2.38e-04 | 1197 | 188 | 24 | GO:0007417 |
| GeneOntologyBiologicalProcess | SNARE complex disassembly | 2.46e-04 | 3 | 188 | 2 | GO:0035494 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | EPHB2 RDX ARHGAP39 ITGA3 ADCYAP1R1 ARHGAP1 LRP4 ARHGAP25 ARHGAP8 ARHGAP21 MUSK | 2.51e-04 | 333 | 188 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 2.54e-04 | 136 | 188 | 7 | GO:1901890 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 SPAG1 CLUAP1 CFAP91 KAT5 STAG1 ACTR10 DYRK1A KAT2A DICER1 HNRNPU WDR19 KAT2B IQCA1 RMDN1 DNAH17 CLTC DNAH5 ARHGAP21 IQUB PHLDB2 CFAP46 | 2.67e-04 | 1058 | 188 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | CLTCL1 PSEN1 INPP5F CUBN TF SCYL2 IGF2R NAPB CLTC STON2 LRP1 | 2.78e-04 | 337 | 188 | 11 | GO:0006898 |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 3.13e-04 | 15 | 188 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | negative regulation of tumor necrosis factor-mediated signaling pathway | 3.13e-04 | 36 | 188 | 4 | GO:0010804 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SPAG1 CLUAP1 CFAP91 KAT5 STAG1 DYRK1A KAT2A DICER1 HNRNPU KAT2B IQCA1 RMDN1 DNAH17 CLTC DNAH5 PHLDB2 CFAP46 | 3.32e-04 | 720 | 188 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | EPHB2 ADCY10 NIBAN1 ABI1 PSEN1 DSCAM INPP5K CD109 APLP2 INPP5F PPARG EZH2 TF DICER1 HNRNPU GH2 GSTP1 KAT2B EPHA2 LRP4 GNAQ MUSK EPHA5 EPHA7 | 3.37e-04 | 1226 | 188 | 24 | GO:0042325 |
| GeneOntologyBiologicalProcess | negative regulation of molecular function | EPHB2 PSEN1 INPP5K CD109 RDX PYDC1 PPARG EZH2 SERPINH1 IFIT2 HNRNPU GSTP1 KAT2B PPP3CA CSNK2A1 CST4 CST5 LAMP3 LRP1 GNAI2 GNAQ | 3.47e-04 | 1005 | 188 | 21 | GO:0044092 |
| GeneOntologyBiologicalProcess | iron ion transport | 3.65e-04 | 67 | 188 | 5 | GO:0006826 | |
| GeneOntologyBiologicalProcess | localization within membrane | EPHB2 SGTA INPP5K RDX FIS1 ITGA3 INPP5F WDR19 ARHGAP1 TTC7B CSNK2A1 EPHA2 CLTC LRP1 PEX5 LRP4 ARHGAP8 MUSK | 3.83e-04 | 798 | 188 | 18 | GO:0051668 |
| GeneOntologyBiologicalProcess | regulation of protein localization | EPHB2 ADCY10 PSEN1 INPP5K SLC26A4 TOR1A RDX FIS1 ITGA3 PPARG PPP3CA CSNK2A1 EPHA2 CLTC LRP1 LRP4 GNAO1 GNAQ AKAP1 HCFC1 MUSK EPHA5 | 3.86e-04 | 1087 | 188 | 22 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | PSEN1 TOR1A RDX INPP5F PPARG TF IL1RAPL1 ARHGAP1 PPP3CA NAPB STON2 LRP1 DNAJC5 GNAI2 ARHGAP8 ARHGAP21 | 4.19e-04 | 667 | 188 | 16 | GO:0060627 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | EPHB2 ADCY10 DSCAM PPARG TF DICER1 GH2 IL1RAPL1 PRMT5 LRP1 MME | 4.22e-04 | 354 | 188 | 11 | GO:0050769 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | SGSM1 CD109 RDX FIS1 PPARG EZH2 ALS2CL SERPINH1 ARHGAP1 CSNK2A1 EPHA2 CST4 CST5 LAMP3 LRP1 ARHGAP25 RCN3 EPHA5 EPHA7 | 4.39e-04 | 878 | 188 | 19 | GO:0051336 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TBC1D19 EPHB2 RPGRIP1 SPAG1 CLUAP1 CFAP91 INPP5K RDX WDR19 P2RX4 ANLN EPHA2 DNAH17 DNAH5 IQUB CFAP46 | 4.40e-04 | 670 | 188 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | EPHB2 NIBAN1 PSEN1 INPP5K CD109 FIS1 INPP5F PPARG HNRNPU GSTP1 KAT2B GNAQ AKAP1 | 4.61e-04 | 478 | 188 | 13 | GO:0045936 |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | SEL1L PSMF1 KAT5 PSEN1 SGTA PSMB5 TOR1A RNF213 IDE EDEM3 PJA2 ERLIN2 CSNK2A1 LAMP3 UGGT2 SEL1L2 UBE3C RCN3 | 4.70e-04 | 812 | 188 | 18 | GO:0051603 |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | EPHB2 NIBAN1 PSEN1 INPP5K CD109 FIS1 INPP5F PPARG HNRNPU GSTP1 KAT2B GNAQ AKAP1 | 4.79e-04 | 480 | 188 | 13 | GO:0010563 |
| GeneOntologyBiologicalProcess | neuron projection retraction | 4.90e-04 | 4 | 188 | 2 | GO:0106028 | |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 4.90e-04 | 4 | 188 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | pachytene | 4.90e-04 | 4 | 188 | 2 | GO:0000239 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 4.93e-04 | 109 | 188 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | intracellular transport | SEL1L CLUAP1 CLTCL1 PSEN1 STARD4 COPZ1 COG7 ACTR10 DYRK1A NAPA RDX INPP5F ALS2CL HNRNPU WDR19 SCYL2 ARHGAP1 IGF2R PPP3CA NAPB CLTC VPS41 LRP1 PEX5 ARHGAP8 AKAP1 ARHGAP21 | 5.06e-04 | 1496 | 188 | 27 | GO:0046907 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 5.20e-04 | 41 | 188 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | EPHB2 BRIP1 PSEN1 INPP5K HMGCS2 IDE PPARG EZH2 GH2 KAT2B PPP3CA P2RX4 PRMT5 LRP1 GNAI2 GNAO1 GNAQ | 5.43e-04 | 752 | 188 | 17 | GO:1901699 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB2 DOCK1 PSEN1 DSCAM SLITRK4 ARHGAP39 ITGA3 IL1RAPL1 SLITRK2 TENM3 IL1RAPL2 LRP4 IL1RAP MUSK EPHA5 EPHA7 | 5.59e-04 | 685 | 188 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell projection assembly | TBC1D19 EPHB2 RPGRIP1 SPAG1 CLUAP1 CFAP91 INPP5K RDX WDR19 P2RX4 ANLN EPHA2 DNAH17 DNAH5 IQUB CFAP46 | 5.59e-04 | 685 | 188 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy in response to stress | 5.71e-04 | 42 | 188 | 4 | GO:0014898 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy in response to stress | 5.71e-04 | 42 | 188 | 4 | GO:0003299 | |
| GeneOntologyBiologicalProcess | endocytosis | DOCK1 CLTCL1 PSEN1 TOR1A INPP5F PPARG CUBN TF SCYL2 IGF2R PPP3CA NAPB CLTC STON2 LRP1 LRP4 ARHGAP25 ARHGAP21 | 5.82e-04 | 827 | 188 | 18 | GO:0006897 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | EPHB2 ADCY10 ABI1 KAT5 PSEN1 INPP5K DYRK1A APLP2 KAT2A INPP5F GH2 KAT2B NAA25 CSNK2A1 PRMT5 DPY19L4 LRP4 CSNK2A3 MUSK EPHA7 | 6.16e-04 | 976 | 188 | 20 | GO:0018193 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG DSC1 DSCAM PCDH11Y PCDHA5 ITGA3 IL1RAPL1 SLITRK2 TENM3 IL1RAP | 6.21e-04 | 313 | 188 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | cardiac muscle adaptation | 6.25e-04 | 43 | 188 | 4 | GO:0014887 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | EPHB2 NR2C2 BRIP1 KAT5 PSEN1 INPP5K HMGCS2 IDE PPARG EZH2 PDIA3 HNRNPU GH2 GSTP1 KAT2B PPP3CA P2RX4 PRMT5 PJVK LRP1 PEX5 GNAI2 GNAO1 GNAQ HCFC1 EPHA5 | 7.14e-04 | 1450 | 188 | 26 | GO:1901701 |
| GeneOntologyBiologicalProcess | organelle assembly | TBC1D19 EPHB2 RPGRIP1 SPAG1 CLUAP1 CFAP91 PSEN1 STAG1 RDX RNF213 KAT2A DICER1 HNRNPU WDR19 KAT2B ANLN DNAH17 CLTC IL1RAP DNAH5 IQUB CFAP46 | 7.14e-04 | 1138 | 188 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 DOCK1 DSCAM SLITRK4 IL1RAPL1 SLITRK2 IL1RAPL2 EPHA2 LRP1 LRP4 IL1RAP MUSK PHLDB2 EPHA7 | 7.52e-04 | 569 | 188 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | chondrocyte differentiation involved in endochondral bone morphogenesis | 7.58e-04 | 20 | 188 | 3 | GO:0003413 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis involved in protein catabolic process | 7.79e-04 | 79 | 188 | 5 | GO:1903051 | |
| GeneOntologyCellularComponent | dendrite | EPHB2 ADCY10 PSEN1 DSCAM DYRK1A APLP2 GRIK1 INPP5F TF DICER1 HNRNPU IL1RAPL1 SLITRK2 PPP3CA P2RX4 LRP1 LRP4 GNAI2 MME GNAO1 GNAQ HCFC1 EPHA10 EPHA5 EPHA7 | 2.53e-07 | 858 | 189 | 25 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 ADCY10 PSEN1 DSCAM DYRK1A APLP2 GRIK1 INPP5F TF DICER1 HNRNPU IL1RAPL1 SLITRK2 PPP3CA P2RX4 LRP1 LRP4 GNAI2 MME GNAO1 GNAQ HCFC1 EPHA10 EPHA5 EPHA7 | 2.64e-07 | 860 | 189 | 25 | GO:0097447 |
| GeneOntologyCellularComponent | coated vesicle | CLTCL1 COPZ1 HLA-C HLA-G INPP5F CUBN TF F8 SCYL2 IGF2R CLTC STON2 VPS41 LRP1 DNAJC5 | 1.05e-06 | 360 | 189 | 15 | GO:0030135 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 DOCK1 ABI1 PSEN1 SLITRK4 HNRNPA3 NAPA GRIK1 ARHGAP39 ITGA3 DICER1 IL1RAPL1 SLITRK2 PPP3CA TENM3 NAPB IL1RAPL2 CLTC LRP1 GNAO1 IL1RAP EPHA7 | 5.04e-06 | 817 | 189 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | EPHB2 DOCK1 ABI1 PSEN1 HNRNPA3 NAPA RPS16 APLP2 GRIK1 ARHGAP39 ITGA3 DICER1 IL1RAPL1 PJA2 SLITRK2 PPP3CA P2RX4 NAPB CLTC LRP1 LRP4 GNAO1 AKAP1 MUSK EPHA7 | 5.53e-06 | 1018 | 189 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 ADCY10 PSEN1 DSCAM DYRK1A APLP2 GRIK1 INPP5F TF DICER1 HNRNPU IL1RAPL1 SLITRK2 PPP3CA P2RX4 PJVK CST4 CST5 LRP1 LRP4 GNAI2 MME GNAO1 GNAQ HCFC1 EPHA10 EPHA5 EPHA7 | 5.86e-06 | 1228 | 189 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | clathrin-coated pit | 8.04e-06 | 80 | 189 | 7 | GO:0005905 | |
| GeneOntologyCellularComponent | neuromuscular junction | 8.21e-06 | 112 | 189 | 8 | GO:0031594 | |
| GeneOntologyCellularComponent | axon | EPHB2 ADCY10 PRTG ABI1 PSEN1 DSCAM ACTR10 DYRK1A TOR1A GRIK1 ITGA3 INPP5F DICER1 IL1RAPL1 P2RX4 TENM3 CST4 CST5 LRP1 MME HCFC1 EPHA5 | 1.95e-05 | 891 | 189 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | dense body | 2.48e-05 | 7 | 189 | 3 | GO:0097433 | |
| GeneOntologyCellularComponent | coated membrane | 5.06e-05 | 106 | 189 | 7 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 5.06e-05 | 106 | 189 | 7 | GO:0030117 | |
| GeneOntologyCellularComponent | clathrin complex | 5.87e-05 | 9 | 189 | 3 | GO:0071439 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 6.22e-05 | 237 | 189 | 10 | GO:0030136 | |
| GeneOntologyCellularComponent | cell surface | EPHB2 PSEN1 HLA-C CD109 HLA-G IDE ITGA3 CUBN TF PDIA3 ADAM28 ADCYAP1R1 HNRNPU IL1RAPL1 IGF2R MUC17 EPHA2 LAMP3 LRP1 TJP2 LRP4 MME MUSK EPHA5 | 6.82e-05 | 1111 | 189 | 24 | GO:0009986 |
| GeneOntologyCellularComponent | synaptic membrane | EPHB2 PSEN1 NAPA GRIK1 ITGA3 IL1RAPL1 SLITRK2 TENM3 NAPB CLTC LRP1 LRP4 GNAO1 AKAP1 MUSK EPHA7 | 8.41e-05 | 583 | 189 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SGSM1 CLTCL1 PSEN1 DSC1 COPZ1 HLA-C SGTA CD109 HLA-G TOR1A APLP2 INPP5F CUBN TF PDIA3 SCYL2 ARHGAP1 IGF2R CLTC STON2 VPS41 LAMP3 LRP1 DNAJC5 MME ARHGAP21 | 1.28e-04 | 1307 | 189 | 26 | GO:0030659 |
| GeneOntologyCellularComponent | clathrin coat | 1.51e-04 | 56 | 189 | 5 | GO:0030118 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.54e-04 | 215 | 189 | 9 | GO:0030662 | |
| GeneOntologyCellularComponent | vesicle membrane | SGSM1 CLTCL1 PSEN1 DSC1 COPZ1 HLA-C SGTA CD109 HLA-G TOR1A APLP2 INPP5F CUBN TF PDIA3 SCYL2 ARHGAP1 IGF2R CLTC STON2 VPS41 LAMP3 LRP1 DNAJC5 MME ARHGAP21 | 1.59e-04 | 1325 | 189 | 26 | GO:0012506 |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.46e-04 | 14 | 189 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.14e-04 | 101 | 189 | 6 | GO:0045334 | |
| GeneOntologyCellularComponent | vesicle coat | 3.51e-04 | 67 | 189 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | ciliary rootlet | 3.74e-04 | 16 | 189 | 3 | GO:0035253 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 4.82e-04 | 4 | 189 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | mitotic spindle | 5.01e-04 | 201 | 189 | 8 | GO:0072686 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | SEL1L DOCK1 SPAG1 PSMF1 KAT5 PSMB5 MCM3 IDE KAT2A DICER1 HNRNPU KAT2B NAA25 PPP3CA CSNK2A1 STIP1 UBE3C CSNK2A3 HCFC1 CNOT3 | 5.30e-04 | 972 | 189 | 20 | GO:0140535 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 6.00e-04 | 114 | 189 | 6 | GO:0005798 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 6.06e-04 | 43 | 189 | 4 | GO:0097431 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 7.11e-04 | 212 | 189 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | endocytic vesicle | CLTCL1 HLA-C HLA-G INPP5F CUBN TF PDIA3 IGF2R CLTC STON2 LRP1 | 7.75e-04 | 384 | 189 | 11 | GO:0030139 |
| GeneOntologyCellularComponent | cell body | EPHB2 ADCY10 PSEN1 DSCAM GRIK1 INPP5F P2RX4 PJVK CST4 CST5 LRP1 LRP4 GNAI2 MME GNAO1 GNAQ HCFC1 EPHA5 EPHA7 | 7.87e-04 | 929 | 189 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | synaptobrevin 2-SNAP-25-syntaxin-1a complex | 7.99e-04 | 5 | 189 | 2 | GO:0070044 | |
| GeneOntologyCellularComponent | myelin sheath | 8.28e-04 | 217 | 189 | 8 | GO:0043209 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ADCY10 PSMF1 KAT5 INPP5K OLFM4 MCM3 ITGA3 PPARG TF DICER1 HEPH ARHGAP1 IGF2R P2RX4 CST4 CST5 LAMP3 LRP1 EPHA5 | 8.39e-04 | 934 | 189 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | secretory granule | PSEN1 DSC1 HLA-C ACTR10 CD109 OLFM4 TOR1A APLP2 TF PDIA3 F8 GH2 GSTP1 IGF2R LAMP3 LRP1 DNAJC5 GNAI2 MME IQUB | 8.95e-04 | 1014 | 189 | 20 | GO:0030141 |
| GeneOntologyCellularComponent | secretory vesicle | PSEN1 DSC1 HLA-C SGTA ACTR10 CD109 OLFM4 TOR1A APLP2 TF PDIA3 F8 GH2 GSTP1 IGF2R CLTC STON2 LAMP3 LRP1 DNAJC5 GNAI2 MME IQUB | 9.05e-04 | 1246 | 189 | 23 | GO:0099503 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.17e-04 | 332 | 189 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | presynaptic membrane | 9.73e-04 | 277 | 189 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | sorting endosome | 1.19e-03 | 6 | 189 | 2 | GO:0097443 | |
| GeneOntologyCellularComponent | peptidase complex | 1.34e-03 | 133 | 189 | 6 | GO:1905368 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.66e-03 | 7 | 189 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | membrane raft | PSEN1 HLA-C ASAH2 HLA-G SERPINH1 ADCYAP1R1 ERLIN2 LRP4 MME GNAQ | 1.75e-03 | 362 | 189 | 10 | GO:0045121 |
| GeneOntologyCellularComponent | growth cone | 1.79e-03 | 245 | 189 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | membrane microdomain | PSEN1 HLA-C ASAH2 HLA-G SERPINH1 ADCYAP1R1 ERLIN2 LRP4 MME GNAQ | 1.82e-03 | 364 | 189 | 10 | GO:0098857 |
| GeneOntologyCellularComponent | endosome | CLTCL1 PSEN1 HLA-C HLA-G IDE INPP5F CUBN TF PDIA3 ADCYAP1R1 SCYL2 GH2 ARHGAP1 IGF2R CLTC CST4 VPS41 CST5 LAMP3 LRP1 MME | 2.07e-03 | 1167 | 189 | 21 | GO:0005768 |
| GeneOntologyCellularComponent | site of polarized growth | 2.19e-03 | 253 | 189 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 2.20e-03 | 8 | 189 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | stereocilium base | 2.20e-03 | 8 | 189 | 2 | GO:0120044 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 2.23e-03 | 147 | 189 | 6 | GO:0030665 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.56e-03 | 104 | 189 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | transport vesicle | CLTCL1 PSEN1 COPZ1 HLA-C SGTA HLA-G TOR1A IGF2R CLTC STON2 DNAJC5 MME | 2.78e-03 | 519 | 189 | 12 | GO:0030133 |
| GeneOntologyCellularComponent | methyltransferase complex | 3.01e-03 | 108 | 189 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.14e-03 | 109 | 189 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | secretory granule membrane | 3.14e-03 | 329 | 189 | 9 | GO:0030667 | |
| GeneOntologyCellularComponent | proteasome complex | 3.18e-03 | 67 | 189 | 4 | GO:0000502 | |
| GeneOntologyCellularComponent | lysosomal membrane | PSEN1 HLA-C HLA-G CUBN P2RX4 CLTC VPS41 LAMP3 LRP1 DNAJC5 GNAQ | 3.32e-03 | 462 | 189 | 11 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | PSEN1 HLA-C HLA-G CUBN P2RX4 CLTC VPS41 LAMP3 LRP1 DNAJC5 GNAQ | 3.32e-03 | 462 | 189 | 11 | GO:0098852 |
| GeneOntologyCellularComponent | MHC class I protein complex | 3.49e-03 | 10 | 189 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 3.72e-03 | 276 | 189 | 8 | GO:0000775 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 3.85e-03 | 35 | 189 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 ADCY10 PSEN1 DSCAM GRIK1 INPP5F P2RX4 PJVK CST4 CST5 LRP1 LRP4 MME HCFC1 EPHA5 EPHA7 | 3.88e-03 | 835 | 189 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic membrane | EPHB2 GRIK1 ITGA3 IL1RAPL1 SLITRK2 LRP1 GNAO1 AKAP1 MUSK EPHA7 | 3.91e-03 | 405 | 189 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | oxoglutarate dehydrogenase complex | 4.24e-03 | 11 | 189 | 2 | GO:0045252 | |
| GeneOntologyCellularComponent | early endosome | CLTCL1 PSEN1 HLA-C HLA-G INPP5F TF IGF2R VPS41 LAMP3 LRP1 MME | 4.48e-03 | 481 | 189 | 11 | GO:0005769 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.77e-03 | 75 | 189 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 4.86e-03 | 38 | 189 | 3 | GO:0030125 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 5.03e-03 | 230 | 189 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | outer dynein arm | 5.06e-03 | 12 | 189 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | chromosomal region | 5.11e-03 | 421 | 189 | 10 | GO:0098687 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.49e-03 | 78 | 189 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 5.62e-03 | 40 | 189 | 3 | GO:0030140 | |
| GeneOntologyCellularComponent | cytoplasmic region | RPGRIP1 CFAP91 ACTR10 HNRNPU DNAH17 DNAH5 IQUB PHLDB2 CFAP46 | 5.62e-03 | 360 | 189 | 9 | GO:0099568 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 5.74e-03 | 79 | 189 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | focal adhesion | 6.00e-03 | 431 | 189 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | GTPase complex | 6.02e-03 | 41 | 189 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | distal axon | 6.39e-03 | 435 | 189 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | vacuolar membrane | PSEN1 HLA-C HLA-G CUBN P2RX4 CLTC VPS41 LAMP3 LRP1 DNAJC5 GNAQ | 6.59e-03 | 507 | 189 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | presynapse | EPHB2 PSEN1 SGTA TOR1A NAPA RPS16 GRIK1 ITGA3 P2RX4 TENM3 NAPB CLTC STON2 DNAJC5 MME GNAO1 | 6.77e-03 | 886 | 189 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | mitotic spindle microtubule | 6.89e-03 | 14 | 189 | 2 | GO:1990498 | |
| GeneOntologyCellularComponent | ATAC complex | 6.89e-03 | 14 | 189 | 2 | GO:0140672 | |
| GeneOntologyCellularComponent | cell-substrate junction | 7.23e-03 | 443 | 189 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | radial spoke | 7.90e-03 | 15 | 189 | 2 | GO:0001534 | |
| Domain | - | SEL1L ADCY10 SPAG1 TTC24 CLTCL1 TTC28 SGTA NAPA FIS1 DNAJC7 IFIT2 WDR19 NAA25 TTC7B NAPB RMDN1 CLTC VPS41 PEX5 STIP1 SEL1L2 CFAP46 | 1.87e-16 | 207 | 189 | 22 | 1.25.40.10 |
| Domain | TPR-like_helical_dom | SEL1L ADCY10 SPAG1 TTC24 CLTCL1 TTC28 SGTA NAPA FIS1 DNAJC7 IFIT2 WDR19 NAA25 TTC7B NAPB RMDN1 CAPN7 CLTC VPS41 PEX5 STIP1 SEL1L2 CFAP46 | 1.92e-16 | 233 | 189 | 23 | IPR011990 |
| Domain | TPR_REGION | SPAG1 TTC24 TTC28 SGTA FIS1 DNAJC7 IFIT2 WDR19 NAA25 TTC7B RMDN1 PEX5 STIP1 CFAP46 | 1.38e-09 | 165 | 189 | 14 | PS50293 |
| Domain | TPR | SPAG1 TTC24 TTC28 SGTA FIS1 DNAJC7 IFIT2 WDR19 NAA25 TTC7B RMDN1 PEX5 STIP1 CFAP46 | 1.38e-09 | 165 | 189 | 14 | PS50005 |
| Domain | TPR-contain_dom | SPAG1 TTC24 TTC28 SGTA FIS1 DNAJC7 IFIT2 WDR19 NAA25 TTC7B PEX5 STIP1 | 4.15e-08 | 150 | 189 | 12 | IPR013026 |
| Domain | TPR_8 | 5.69e-08 | 53 | 189 | 8 | PF13181 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.87e-07 | 14 | 189 | 5 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.87e-07 | 14 | 189 | 5 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.87e-07 | 14 | 189 | 5 | IPR001426 | |
| Domain | EphA2_TM | 1.87e-07 | 14 | 189 | 5 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.87e-07 | 14 | 189 | 5 | IPR001090 | |
| Domain | Eph_TM | 1.87e-07 | 14 | 189 | 5 | IPR027936 | |
| Domain | EPH_lbd | 1.87e-07 | 14 | 189 | 5 | SM00615 | |
| Domain | Ephrin_lbd | 1.87e-07 | 14 | 189 | 5 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.87e-07 | 14 | 189 | 5 | IPR016257 | |
| Domain | EPH_LBD | 1.87e-07 | 14 | 189 | 5 | PS51550 | |
| Domain | TPR_1 | 3.21e-07 | 90 | 189 | 9 | IPR001440 | |
| Domain | TPR_1 | 3.21e-07 | 90 | 189 | 9 | PF00515 | |
| Domain | Clathrin | 3.47e-07 | 7 | 189 | 4 | PF00637 | |
| Domain | Clathrin_H-chain/VPS_repeat | 6.89e-07 | 8 | 189 | 4 | IPR000547 | |
| Domain | CLH | 1.02e-06 | 3 | 189 | 3 | SM00299 | |
| Domain | EGF_2 | EPHB2 ATRN CUBN ADAM28 TENM3 MUC17 EPHA2 LRP1 LRP4 C1R EPHA10 EPHA5 EPHA7 | 3.17e-06 | 265 | 189 | 13 | PS01186 |
| Domain | Ephrin_rec_like | 4.54e-06 | 25 | 189 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 4.54e-06 | 25 | 189 | 5 | IPR011641 | |
| Domain | TPR | 6.63e-06 | 129 | 189 | 9 | SM00028 | |
| Domain | TPR_repeat | 8.51e-06 | 133 | 189 | 9 | IPR019734 | |
| Domain | EGF-like_CS | ATRN CUBN ADAM28 TENM3 MUC17 EPHA2 LRP1 LRP4 C1R EPHA10 EPHA5 EPHA7 | 1.47e-05 | 261 | 189 | 12 | IPR013032 |
| Domain | CHCR | 3.46e-05 | 7 | 189 | 3 | PS50236 | |
| Domain | PAZ | 8.19e-05 | 9 | 189 | 3 | PS50821 | |
| Domain | PAZ | 8.19e-05 | 9 | 189 | 3 | SM00949 | |
| Domain | PAZ | 8.19e-05 | 9 | 189 | 3 | PF02170 | |
| Domain | PAZ_dom | 8.19e-05 | 9 | 189 | 3 | IPR003100 | |
| Domain | - | 9.62e-05 | 73 | 189 | 6 | 2.60.120.260 | |
| Domain | Clathrin_H-chain_propeller_rpt | 1.02e-04 | 2 | 189 | 2 | IPR022365 | |
| Domain | Clathrin-link | 1.02e-04 | 2 | 189 | 2 | PF09268 | |
| Domain | - | 1.02e-04 | 2 | 189 | 2 | 2.130.10.110 | |
| Domain | EZH1/EZH2 | 1.02e-04 | 2 | 189 | 2 | IPR021654 | |
| Domain | Hist_acetylase_PCAF | 1.02e-04 | 2 | 189 | 2 | IPR016376 | |
| Domain | Clathrin_heavy_chain | 1.02e-04 | 2 | 189 | 2 | IPR016341 | |
| Domain | CXC | 1.02e-04 | 2 | 189 | 2 | PS51633 | |
| Domain | ZF_CCHC_HIVEP | 1.02e-04 | 2 | 189 | 2 | PS51811 | |
| Domain | Clathrin_H-chain_propeller_N | 1.02e-04 | 2 | 189 | 2 | IPR001473 | |
| Domain | EZH2_WD-Binding | 1.02e-04 | 2 | 189 | 2 | PF11616 | |
| Domain | PCAF_N | 1.02e-04 | 2 | 189 | 2 | IPR009464 | |
| Domain | Clathrin_H-chain_link/propller | 1.02e-04 | 2 | 189 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.02e-04 | 2 | 189 | 2 | PF01394 | |
| Domain | CXC_dom | 1.02e-04 | 2 | 189 | 2 | IPR026489 | |
| Domain | Clathrin_H-chain_linker_core | 1.02e-04 | 2 | 189 | 2 | IPR015348 | |
| Domain | PCAF_N | 1.02e-04 | 2 | 189 | 2 | PF06466 | |
| Domain | IL-1_rcpt_fam | 1.59e-04 | 11 | 189 | 3 | IPR015621 | |
| Domain | Growth_fac_rcpt_ | 1.92e-04 | 156 | 189 | 8 | IPR009030 | |
| Domain | Tyr_kinase_cat_dom | 2.70e-04 | 88 | 189 | 6 | IPR020635 | |
| Domain | TyrKc | 2.70e-04 | 88 | 189 | 6 | SM00219 | |
| Domain | Clathrin_H-chain_linker | 3.04e-04 | 3 | 189 | 2 | IPR012331 | |
| Domain | NSF_attach | 3.04e-04 | 3 | 189 | 2 | IPR000744 | |
| Domain | Cu-oxidase | 3.04e-04 | 3 | 189 | 2 | PF00394 | |
| Domain | Cu-oxidase | 3.04e-04 | 3 | 189 | 2 | IPR001117 | |
| Domain | Galactose-bd-like | 3.86e-04 | 94 | 189 | 6 | IPR008979 | |
| Domain | RhoGAP | 4.08e-04 | 62 | 189 | 5 | SM00324 | |
| Domain | RhoGAP | 4.40e-04 | 63 | 189 | 5 | PF00620 | |
| Domain | PROTEIN_KINASE_TYR | 4.57e-04 | 97 | 189 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.57e-04 | 97 | 189 | 6 | IPR008266 | |
| Domain | RhoGAP_dom | 4.73e-04 | 64 | 189 | 5 | IPR000198 | |
| Domain | RHOGAP | 4.73e-04 | 64 | 189 | 5 | PS50238 | |
| Domain | - | 4.73e-04 | 64 | 189 | 5 | 1.10.555.10 | |
| Domain | GproteinA_insert | 5.18e-04 | 16 | 189 | 3 | IPR011025 | |
| Domain | - | 5.18e-04 | 16 | 189 | 3 | 1.10.400.10 | |
| Domain | G-alpha | 5.18e-04 | 16 | 189 | 3 | PF00503 | |
| Domain | G_alpha | 5.18e-04 | 16 | 189 | 3 | SM00275 | |
| Domain | Cu-oxidase_2 | 6.03e-04 | 4 | 189 | 2 | IPR011706 | |
| Domain | Cu-oxidase_2 | 6.03e-04 | 4 | 189 | 2 | PF07731 | |
| Domain | FN3 | 6.04e-04 | 185 | 189 | 8 | SM00060 | |
| Domain | Gprotein_alpha_su | 6.25e-04 | 17 | 189 | 3 | IPR001019 | |
| Domain | SAM_1 | 6.26e-04 | 68 | 189 | 5 | PF00536 | |
| Domain | FN3 | 9.71e-04 | 199 | 189 | 8 | PS50853 | |
| Domain | Cu-oxidase_3 | 9.98e-04 | 5 | 189 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 9.98e-04 | 5 | 189 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 9.98e-04 | 5 | 189 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 9.98e-04 | 5 | 189 | 2 | PF07732 | |
| Domain | TIR | 1.19e-03 | 21 | 189 | 3 | SM00255 | |
| Domain | SAM/pointed | 1.23e-03 | 117 | 189 | 6 | IPR013761 | |
| Domain | ER_TARGET | 1.29e-03 | 47 | 189 | 4 | PS00014 | |
| Domain | fn3 | 1.33e-03 | 162 | 189 | 7 | PF00041 | |
| Domain | FN3_dom | 1.33e-03 | 209 | 189 | 8 | IPR003961 | |
| Domain | TIR | 1.36e-03 | 22 | 189 | 3 | PF01582 | |
| Domain | Tesmin/TSO1-like_CXC | 1.49e-03 | 6 | 189 | 2 | IPR033467 | |
| Domain | Cu_oxidase_Cu_BS | 1.49e-03 | 6 | 189 | 2 | IPR002355 | |
| Domain | ArgoL1 | 1.49e-03 | 6 | 189 | 2 | PF08699 | |
| Domain | ArgoL1 | 1.49e-03 | 6 | 189 | 2 | IPR014811 | |
| Domain | CXC | 1.49e-03 | 6 | 189 | 2 | SM01114 | |
| Domain | - | ADCY10 ABCB7 BRIP1 IFI44 TOR1A RNF213 MCM3 DICER1 HNRNPU IQCA1 N4BP2 GPN2 TJP2 GNAI2 GNAO1 GNAQ DNAH5 | 1.55e-03 | 746 | 189 | 17 | 3.40.50.300 |
| Domain | - | 1.56e-03 | 23 | 189 | 3 | 3.40.50.10140 | |
| Domain | TPR_2 | 1.63e-03 | 50 | 189 | 4 | PF07719 | |
| Domain | TPR_2 | 1.63e-03 | 50 | 189 | 4 | IPR013105 | |
| Domain | TIR | 1.77e-03 | 24 | 189 | 3 | PS50104 | |
| Domain | TIR_dom | 1.99e-03 | 25 | 189 | 3 | IPR000157 | |
| Domain | Rho_GTPase_activation_prot | 2.00e-03 | 88 | 189 | 5 | IPR008936 | |
| Domain | SAM | 2.00e-03 | 88 | 189 | 5 | SM00454 | |
| Domain | Pkinase_Tyr | 2.02e-03 | 129 | 189 | 6 | PF07714 | |
| Domain | TPR_11 | 2.07e-03 | 7 | 189 | 2 | PF13414 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.12e-07 | 51 | 163 | 8 | M27311 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 2.62e-06 | 20 | 163 | 5 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 2.62e-06 | 20 | 163 | 5 | MM14991 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.10e-05 | 92 | 163 | 8 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 4.12e-05 | 34 | 163 | 5 | MM15025 | |
| Pubmed | SEL1L ATRN ABCB7 HLA-C OTUB1 CD109 HNRNPA3 TOR1A TRMT11 RPS16 RDX OAT ITGA3 DNAJC7 SERPINH1 PDIA3 HNRNPU GSTP1 ARHGAP1 EDEM3 ERLIN2 IGF2R PPP3CA ANLN CSNK2A1 CLTC UGGT2 GNAI2 STIP1 UBE3C AKAP1 HCCS HCFC1 CNOT3 RCN3 | 4.84e-15 | 1297 | 190 | 35 | 33545068 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L EPHB2 ATRN NR2C2 ABCB7 HLA-C SLITRK4 CD109 TOR1A RNF213 APLP2 ITGA3 SERPINH1 PDIA3 EDEM3 THADA ERLIN2 IGF2R TENM3 STRAP EPHA2 PRMT5 DPY19L4 LRP1 LRP4 UGGT2 GNAI2 IL1RAP AKAP1 ARHGAP21 RCN3 | 6.83e-13 | 1201 | 190 | 31 | 35696571 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 AMPD1 SPAG1 PSMF1 DSC1 SGTA OTUB1 PSMB5 HNRNPA3 NAPA RNF213 IDE DNAJC7 SERPINH1 PDIA3 WTAP HNRNPU ARHGAP1 NAA25 IGF2R ANLN RMDN1 EPHA2 CLTC CST4 LRP1 TJP2 UPP1 GNAI2 STIP1 GNAO1 HCFC1 PHLDB2 | 7.00e-13 | 1367 | 190 | 33 | 32687490 |
| Pubmed | SEL1L ABCB7 CLTCL1 COG7 OTUB1 PSMB5 CD109 AGPAT4 HNRNPA3 NAPA RNF213 MCM3 OAT DNAJC7 SERPINH1 PDIA3 NDUFB10 DICER1 HNRNPU GSTP1 THADA ERLIN2 STRAP PRMT5 CLTC TJP2 LRP4 PCMTD2 STIP1 UBE3C HCFC1 CNOT3 | 1.42e-11 | 1440 | 190 | 32 | 30833792 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 DSC1 HLA-C OTUB1 PSMB5 HNRNPA3 RPS16 RDX MCM3 APLP2 OAT IDE DBT DNAJC7 SERPINH1 PDIA3 DICER1 HNRNPU GSTP1 THADA ERLIN2 IGF2R STRAP CSNK2A1 PRMT5 CLTC STIP1 UBE3C DNAH5 HCFC1 | 2.44e-10 | 1425 | 190 | 30 | 30948266 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEL1L NIBAN1 ABCB7 COPZ1 HLA-C CD109 HNRNPA3 HLA-G IFI44 DYRK1A RPS16 RNF213 MCM3 OAT DBT SERPINH1 PDIA3 NDUFB10 HNRNPU TMEM11 ERLIN2 IGF2R CLTC CST4 CST5 LRP1 C1R UGGT2 GNAI2 RCN3 | 3.74e-10 | 1451 | 190 | 30 | 30550785 |
| Pubmed | ATRN CFAP91 DSCAM STAG1 TTC28 SGTA DYRK1A NAPA RDX OAT GRIK1 DNAJC7 TF WDR19 SCYL2 ARHGAP1 NAA25 PPP3CA TTC7B NAPB ZNF655 CLTC LRP1 LRP4 PCMTD2 ARHGAP21 CNOT3 | 2.22e-09 | 1285 | 190 | 27 | 35914814 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB2 NR2C2 HLA-C COG7 HLA-G TOR1A NAPA RNF213 OAT HMGCS2 ITGA3 PDIA3 DICER1 THADA IGF2R STRAP EPHA2 DPY19L4 VPS41 UGGT2 STIP1 GNAQ UBE3C ST8SIA4 | 4.61e-09 | 1061 | 190 | 24 | 33845483 |
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 8.88e-09 | 14 | 190 | 5 | 11222144 | |
| Pubmed | DSCAM COPZ1 TTC28 RPS16 RNF213 MCM3 GSTP1 ARHGAP1 THADA ERLIN2 IGF2R PPP3CA TENM3 EPHA2 CLTC PEX5 TJP2 ZFHX3 AKAP1 ARHGAP21 | 1.18e-08 | 777 | 190 | 20 | 35844135 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DSC1 HLA-C INPP5K PSMB5 CD109 HNRNPA3 RPS16 MCM3 OAT DBT SERPINH1 NDUFB10 WTAP HNRNPU GSTP1 ARHGAP1 STRAP ANLN CSNK2A1 PRMT5 CLTC STON2 TJP2 GNAI2 PHLDB2 | 2.71e-08 | 1257 | 190 | 25 | 36526897 |
| Pubmed | NIBAN1 IL32 PSMF1 CLTCL1 HLA-C INPP5K HLA-G NAPA RPS16 RNF213 MCM3 APLP2 FIS1 DNAJC7 HNRNPU IGF2R P2RX4 CLTC DNAJC5 ETNK1 GNAI2 IL1RAP AKAP1 HCFC1 | 2.87e-08 | 1168 | 190 | 24 | 19946888 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATRN ABI1 PRXL2B SLC26A4 OTUB1 PSMB5 OLFM4 NAPA RDX ITGA3 CUBN DNAJC7 TF GSTP1 ARHGAP1 IGF2R P2RX4 CAPN7 CLTC GNAI2 MME GNAQ | 4.58e-08 | 1016 | 190 | 22 | 19056867 |
| Pubmed | SEL1L ATRN HLA-C MCM3 OAT ITGA3 SERPINH1 HEPH SCYL2 EDEM3 ERLIN2 IGF2R STRAP PRMT5 CLTC LRP1 UGGT2 | 5.41e-08 | 613 | 190 | 17 | 22268729 | |
| Pubmed | 5.94e-08 | 8 | 190 | 4 | 15944124 | ||
| Pubmed | PSEN1 HNRNPA3 OAT FIS1 TF PDIA3 NDUFB10 HNRNPU GSTP1 STRAP STON2 LRP1 LRP4 DNAJC5 GNAI2 MME GNAO1 HCCS HCFC1 RCN3 | 6.11e-08 | 859 | 190 | 20 | 31536960 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L OTUB1 PSMB5 CD109 HNRNPA3 APLP2 OAT IDE TF PDIA3 DICER1 ARHGAP1 ERLIN2 CSNK2A1 EPHA2 LRP1 TJP2 UPP1 GNAI2 STIP1 UBE3C | 1.02e-07 | 974 | 190 | 21 | 28675297 |
| Pubmed | 1.06e-07 | 9 | 190 | 4 | 11403717 | ||
| Pubmed | 1.06e-07 | 9 | 190 | 4 | 23986861 | ||
| Pubmed | BRIP1 TTC28 RNF213 DICER1 EDEM3 ERLIN2 IGF2R WDHD1 STRAP ANLN N4BP2 PEX5 TJP2 DNAJC5 UGGT2 UBE3C AKAP1 HCFC1 | 1.33e-07 | 733 | 190 | 18 | 34672954 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 1.45e-07 | 149 | 190 | 9 | 26370502 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | CD109 RPS16 MCM3 OAT KAT2A PDIA3 HNRNPU GSTP1 STRAP EPHA2 CLTC STON2 GNAI2 STIP1 GNAO1 GNAQ | 1.45e-07 | 580 | 190 | 16 | 35676659 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HIVEP1 DSC1 TTC28 SGTA OTUB1 PSMB5 TRMT11 RDX OAT KAT2A DBT DICER1 PJA2 IGF2R CSNK2A1 LRP1 TJP2 UGGT2 STIP1 AKAP1 HCFC1 | 1.71e-07 | 1005 | 190 | 21 | 19615732 |
| Pubmed | NR2C2 ABCB7 HLA-C SGTA OTUB1 TOR1A OAT DBT DNAJC7 PDIA3 NDUFB10 DICER1 WDR19 ARHGAP1 PJA2 THADA IGF2R PTCD1 N4BP2 EPHA2 CLTC DNAJC5 UGGT2 STIP1 AKAP1 EPHA7 | 1.76e-07 | 1487 | 190 | 26 | 33957083 | |
| Pubmed | 1.77e-07 | 10 | 190 | 4 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 1.77e-07 | 10 | 190 | 4 | 16547242 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 1.77e-07 | 10 | 190 | 4 | 17304517 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | PSMB5 DYRK1A MCM3 INPP5F SERPINH1 PJA2 ERLIN2 WDHD1 CSNK2A1 EPHA2 UBE3C HCFC1 | 1.78e-07 | 313 | 190 | 12 | 38270169 |
| Pubmed | 2.76e-07 | 11 | 190 | 4 | 22065784 | ||
| Pubmed | SEL1L RPS16 MCM3 OAT IDE TF PDIA3 HNRNPU GSTP1 ERLIN2 CLTC STIP1 | 2.84e-07 | 327 | 190 | 12 | 31409639 | |
| Pubmed | ABI1 PRXL2B HNRNPA3 DYRK1A RPS16 RDX OAT ARHGAP39 TF PDIA3 HNRNPU GSTP1 ERLIN2 PPP3CA TTC7B NAPB CSNK2A1 PRMT5 CLTC STON2 TJP2 STIP1 GNAO1 GNAQ ARHGAP21 | 3.15e-07 | 1431 | 190 | 25 | 37142655 | |
| Pubmed | ADCY10 KAT5 PSMB5 HNRNPA3 TRMT11 RPS16 MCM3 DBT DNAJC7 SERPINH1 PDIA3 DICER1 WTAP HNRNPU PJA2 PPP3CA STRAP PTCD1 CSNK2A1 PRMT5 CLTC STON2 STIP1 HCFC1 | 3.33e-07 | 1335 | 190 | 24 | 29229926 | |
| Pubmed | ABI1 DSCAM DYRK1A RDX MCM3 ARHGAP39 HNRNPU IGF2R PPP3CA STRAP N4BP2 CSNK2A1 CLTC STON2 LRP1 PEX5 STIP1 GNAO1 ARHGAP21 PHLDB2 | 3.76e-07 | 963 | 190 | 20 | 28671696 | |
| Pubmed | COPZ1 PSMB5 HNRNPA3 RPS16 RDX MCM3 OAT DBT DNAJC7 SERPINH1 PDIA3 WTAP HNRNPU GSTP1 ERLIN2 EPHA2 PRMT5 CLTC GNAI2 STIP1 HCFC1 CNOT3 PHLDB2 | 3.84e-07 | 1247 | 190 | 23 | 27684187 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NIBAN1 COPZ1 COG7 SGTA ACTR10 PSMB5 RPS16 RDX MCM3 IDE DNAJC7 SERPINH1 PDIA3 HNRNPU PPP3CA WDHD1 STRAP CSNK2A1 PRMT5 PEX5 TJP2 GNAI2 STIP1 UBE3C HCFC1 | 4.28e-07 | 1455 | 190 | 25 | 22863883 |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 5.70e-07 | 55 | 190 | 6 | 38945485 | |
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 6.39e-07 | 4 | 190 | 3 | 7898931 | |
| Pubmed | 6.39e-07 | 4 | 190 | 3 | 21737611 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 DOCK1 ATRN PSMF1 SGSM1 SGTA PCDH11Y HNRNPA3 NAPA RNF213 GRIK1 IDE ARHGAP39 HNRNPU ZNF248 HIVEP3 THADA PPP3CA ANKAR VPS41 LRP1 ZFHX3 MME UBE3C ARHGAP8 | 6.53e-07 | 1489 | 190 | 25 | 28611215 |
| Pubmed | BRIP1 PSMB5 HNRNPA3 DYRK1A RPS16 MCM3 SERPINH1 HNRNPU STRAP PRMT5 CLTC PCMTD2 STIP1 HCFC1 | 6.53e-07 | 494 | 190 | 14 | 26831064 | |
| Pubmed | 7.07e-07 | 132 | 190 | 8 | 22496890 | ||
| Pubmed | KAT5 TTC28 INPP5K RNF213 KAT2A ITGA3 DBT EZH1 TF DICER1 EDEM3 PJA2 ZNF610 KAT2B THADA CSNK2A1 LRP1 PEX5 LRP4 ZFHX3 PHLDB2 | 9.31e-07 | 1116 | 190 | 21 | 31753913 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NIBAN1 HLA-C HNRNPA3 TOR1A MCM3 DNAJC7 SERPINH1 PDIA3 DICER1 HNRNPU GSTP1 IGF2R CSNK2A1 PRMT5 CLTC PEX5 TJP2 GNAI2 STIP1 PHLDB2 | 9.74e-07 | 1024 | 190 | 20 | 24711643 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RPGRIP1 SPAG1 CLUAP1 CFAP91 ABI1 COPZ1 ACTR10 OTUB1 DYRK1A MCM3 APLP2 TF PDIA3 DICER1 WDR19 SCYL2 THADA ERLIN2 CSNK2A1 CST4 UGGT2 HCCS PHLDB2 | 1.03e-06 | 1321 | 190 | 23 | 27173435 |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | SEL1L SGTA PSMB5 NAPA RDX APLP2 DNAJC7 SERPINH1 PDIA3 GSTP1 ERLIN2 IGF2R DNAJC5 STIP1 | 1.09e-06 | 516 | 190 | 14 | 36610398 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCB7 COPZ1 TTC28 ACTR10 DYRK1A MCM3 DBT DNAJC7 ARHGAP1 PJA2 IGF2R N4BP2 CAPN7 PRMT5 PEX5 TJP2 UBE3C ARHGAP21 | 1.19e-06 | 853 | 190 | 18 | 28718761 |
| Pubmed | 1.31e-06 | 35 | 190 | 5 | 30942445 | ||
| Pubmed | 1.49e-06 | 16 | 190 | 4 | 8755474 | ||
| Pubmed | Gcn5 and PCAF regulate PPARγ and Prdm16 expression to facilitate brown adipogenesis. | 1.59e-06 | 5 | 190 | 3 | 25071153 | |
| Pubmed | Specific interaction of the 70-kDa heat shock cognate protein with the tetratricopeptide repeats. | 1.59e-06 | 5 | 190 | 3 | 10567422 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 9660808 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 19949912 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DOCK1 STAG1 NAPA DNAJC7 DICER1 TMEM11 NAA25 TENM3 TJP2 DNAJC5 ETNK1 ZFHX3 PCMTD2 UBE3C | 1.70e-06 | 536 | 190 | 14 | 15840001 |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.72e-06 | 200 | 190 | 9 | 35546148 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.75e-06 | 258 | 190 | 10 | 21081666 | |
| Pubmed | DOCK1 STAG1 NAPA DNAJC7 DICER1 TMEM11 NAA25 TENM3 TJP2 DNAJC5 ETNK1 ZFHX3 PCMTD2 UBE3C | 1.78e-06 | 538 | 190 | 14 | 10512203 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ATRN NIBAN1 CLTCL1 DSC1 OTUB1 OLFM4 NAPA RDX CUBN TF GSTP1 ARHGAP1 IGF2R P2RX4 NAPB CAPN7 CLTC C1R MME GNAQ | 1.90e-06 | 1070 | 190 | 20 | 23533145 |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 1.94e-06 | 17 | 190 | 4 | 12217323 | |
| Pubmed | OTUB1 HNRNPA3 FIS1 TF PDIA3 HNRNPU GSTP1 NAPB CSNK2A1 CLTC DNAJC5 GNAI2 STIP1 GNAO1 | 2.39e-06 | 552 | 190 | 14 | 36293380 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SPAG1 APLP2 ARHGAP39 PDIA3 SCYL2 GSTP1 ARHGAP1 THADA ERLIN2 IGF2R TENM3 PEX5 LRP4 DNAJC5 ARHGAP21 EPHA7 | 2.44e-06 | 719 | 190 | 16 | 35337019 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ABCB7 TTC28 PSMB5 HNRNPA3 TRMT11 RNF213 OAT FIS1 IDE LARP1B DBT DNAJC7 PDIA3 NDUFB10 SCYL2 ARHGAP1 THADA ERLIN2 CLTC PEX5 STIP1 UBE3C AKAP1 HCCS | 2.45e-06 | 1496 | 190 | 24 | 32877691 |
| Pubmed | 2.60e-06 | 40 | 190 | 5 | 20308539 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPAG1 ABI1 HLA-C RDX SCYL2 ARHGAP1 IGF2R TENM3 ANLN EPHA2 TJP2 HCFC1 ARHGAP21 PHLDB2 | 3.13e-06 | 565 | 190 | 14 | 25468996 |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 3.14e-06 | 19 | 190 | 4 | 12684176 | |
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 3.17e-06 | 6 | 190 | 3 | 11253162 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 12154097 | ||
| Pubmed | Roles of MIWI, MILI and PLD6 in small RNA regulation in mouse growing oocytes. | 3.17e-06 | 6 | 190 | 3 | 28115634 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 21987584 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 3.33e-06 | 42 | 190 | 5 | 11439183 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SPAG1 ABI1 HLA-C SLITRK4 APLP2 ITGA3 SLITRK2 IGF2R EPHA2 STON2 GNAQ ARHGAP21 PHLDB2 EPHA7 | 3.39e-06 | 569 | 190 | 14 | 30639242 |
| Pubmed | 3.61e-06 | 164 | 190 | 8 | 32409323 | ||
| Pubmed | SEL1L SGTA TOR1A APLP2 DNAJC7 PDIA3 NDUFB10 HNRNPU PJA2 THADA ERLIN2 IGF2R STRAP PRMT5 CLTC | 3.73e-06 | 657 | 190 | 15 | 36180527 | |
| Pubmed | 3.88e-06 | 117 | 190 | 7 | 17145500 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 3.90e-06 | 20 | 190 | 4 | 11256076 | |
| Pubmed | 3.90e-06 | 20 | 190 | 4 | 10207129 | ||
| Pubmed | 3.90e-06 | 20 | 190 | 4 | 9530499 | ||
| Pubmed | 3.90e-06 | 20 | 190 | 4 | 9576626 | ||
| Pubmed | 4.35e-06 | 224 | 190 | 9 | 32941674 | ||
| Pubmed | 4.80e-06 | 21 | 190 | 4 | 9267020 | ||
| Pubmed | 4.80e-06 | 21 | 190 | 4 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 4.80e-06 | 21 | 190 | 4 | 10730216 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 4.80e-06 | 21 | 190 | 4 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 4.80e-06 | 21 | 190 | 4 | 20112066 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ABI1 COPZ1 SGTA ACTR10 OTUB1 HNRNPA3 RPS16 RDX MCM3 DNAJC7 SERPINH1 PDIA3 HNRNPU GSTP1 STRAP CSNK2A1 PRMT5 CLTC STIP1 HCFC1 | 5.51e-06 | 1149 | 190 | 20 | 35446349 |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 15251452 | ||
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 17920016 | ||
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 19005074 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 5.58e-06 | 231 | 190 | 9 | 36597993 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ABCB7 DSC1 HLA-C SGTA PSMB5 HNRNPA3 RPS16 MCM3 OAT DNAJC7 SERPINH1 NDUFB10 WTAP HNRNPU ERLIN2 PPP3CA STRAP PRMT5 CLTC UBE3C HCFC1 | 5.94e-06 | 1257 | 190 | 21 | 37317656 |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 7.04e-06 | 128 | 190 | 7 | 25332235 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 7.04e-06 | 23 | 190 | 4 | 25480914 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 7.04e-06 | 23 | 190 | 4 | 19542359 | |
| Pubmed | 7.04e-06 | 23 | 190 | 4 | 31281901 | ||
| Pubmed | COPZ1 SGTA PSMB5 HNRNPA3 RPS16 MCM3 LARP1B DNAJC7 SERPINH1 WTAP HNRNPU KAT2B WDHD1 STRAP PRMT5 LRP1 STIP1 HCCS | 7.14e-06 | 971 | 190 | 18 | 33306668 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 8.42e-06 | 24 | 190 | 4 | 16446123 | |
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 8.81e-06 | 8 | 190 | 3 | 12509430 | |
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 18641335 | ||
| Pubmed | 8.84e-06 | 51 | 190 | 5 | 19769959 | ||
| Pubmed | PSMB5 HNRNPA3 NAPA RPS16 MCM3 HNRNPU GSTP1 ERLIN2 IGF2R STRAP CSNK2A1 PRMT5 CLTC STON2 STIP1 | 8.95e-06 | 707 | 190 | 15 | 19738201 | |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | HIVEP1 HLA-C SGTA PSMB5 HNRNPA3 RNF213 HNRNPU HIVEP3 ERLIN2 CSNK2A1 | 9.63e-06 | 313 | 190 | 10 | 16196087 |
| Interaction | RHOB interactions | EPHB2 DOCK1 SPAG1 ABCB7 ABI1 HLA-C SLITRK4 ARHGAP39 ITGA3 HNRNPU SCYL2 ARHGAP1 IGF2R TTC7B TENM3 ANLN EPHA2 CLTC STON2 TJP2 LRP4 GNAI2 IL1RAP ARHGAP21 PHLDB2 SLC35A5 EPHA5 EPHA7 | 6.13e-09 | 840 | 190 | 28 | int:RHOB |
| Interaction | HYOU1 interactions | SEL1L EPHB2 NR2C2 CLUAP1 CLTCL1 CD109 NAPA EZH2 DNAJC7 EDEM3 TENM3 ANLN STIP1 AKAP1 EPHA10 | 3.55e-07 | 317 | 190 | 15 | int:HYOU1 |
| Interaction | METTL14 interactions | CLTCL1 DSC1 HNRNPA3 RPS16 MCM3 HPSE2 LARP1B SERPINH1 PDIA3 WTAP HNRNPU STRAP ANLN CSNK2A1 PRMT5 GNAI2 STIP1 GNAO1 CSNK2A3 | 1.48e-06 | 558 | 190 | 19 | int:METTL14 |
| Interaction | RAC2 interactions | DOCK1 NR2C2 ABCB7 ABI1 HLA-C SLITRK4 NAPA RDX ARHGAP39 EZH2 ARHGAP1 IGF2R TENM3 EPHA2 CLTC STON2 AKAP1 ARHGAP21 PHLDB2 EPHA5 EPHA7 | 1.67e-06 | 674 | 190 | 21 | int:RAC2 |
| Interaction | CALR interactions | NR2C2 HLA-C RDX ARHGAP39 ITGA3 EZH2 SERPINH1 TF PDIA3 F8 HNRNPU EDEM3 LRP1 UBE3C AKAP1 EPHA10 | 2.09e-06 | 414 | 190 | 16 | int:CALR |
| Interaction | CD274 interactions | DSC1 STAG1 COG7 SGTA OTUB1 PSMB5 HNRNPA3 OAT PDIA3 SCYL2 THADA CSNK2A1 STIP1 UBE3C CSNK2A3 | 2.38e-06 | 369 | 190 | 15 | int:CD274 |
| Interaction | ST13 interactions | NR2C2 PSEN1 SGTA RDX GRIK1 ARHGAP39 DNAJC7 CLTC DNAJC5 STIP1 AKAP1 | 2.53e-06 | 195 | 190 | 11 | int:ST13 |
| Interaction | PDIA3 interactions | SGTA OTUB1 PSMB5 HNRNPA3 ARHGAP39 ITGA3 EZH2 SERPINH1 PDIA3 EDEM3 THADA WDHD1 EPHA2 DNAJC5 UBE3C AKAP1 EPHA10 | 2.88e-06 | 476 | 190 | 17 | int:PDIA3 |
| Interaction | HSP90B1 interactions | SEL1L NR2C2 NAPA MCM3 GRIK1 EZH2 PDIA3 HNRNPU SCYL2 EDEM3 ERLIN2 ANLN CSNK2A1 DNAH17 CLTC LRP1 STIP1 UBE3C AKAP1 EPHA10 | 3.63e-06 | 650 | 190 | 20 | int:HSP90B1 |
| Interaction | LMAN1 interactions | NR2C2 COPZ1 FIS1 DNAJC7 IFIT2 F8 HNRNPU ARHGAP1 EDEM3 IGF2R EPHA2 LAMP3 DNAJC5 STIP1 AKAP1 EPHA10 | 4.68e-06 | 441 | 190 | 16 | int:LMAN1 |
| Interaction | HSPA1B interactions | EPHB2 PPARG EZH2 DNAJC7 PDIA3 ANLN CSNK2A1 EPHA2 STIP1 MUSK EPHA10 EPHA5 EPHA7 | 5.96e-06 | 301 | 190 | 13 | int:HSPA1B |
| Interaction | BRCA1 interactions | RPGRIP1 BRIP1 HIVEP1 KAT5 STAG1 TTC28 PSMB5 HNRNPA3 DYRK1A RPS16 RDX MCM3 APLP2 CUBN EZH2 SERPINH1 HNRNPU WDHD1 STRAP ANLN CSNK2A1 PRMT5 CLTC PEX5 PCMTD2 STIP1 UBE3C HCFC1 ARHGAP21 | 6.18e-06 | 1249 | 190 | 29 | int:BRCA1 |
| Interaction | DNAJB12 interactions | 6.20e-06 | 174 | 190 | 10 | int:DNAJB12 | |
| Interaction | SERPINH1 interactions | NR2C2 PPARG EZH2 DNAJC7 SERPINH1 PDIA3 ARHGAP1 EDEM3 KAT2B ANLN STIP1 AKAP1 EPHA10 | 7.11e-06 | 306 | 190 | 13 | int:SERPINH1 |
| Interaction | RRM1 interactions | 7.81e-06 | 141 | 190 | 9 | int:RRM1 | |
| Interaction | TMEM106B interactions | SEL1L ATRN HLA-C CD109 TOR1A ITGA3 SERPINH1 PDIA3 EDEM3 ERLIN2 LAMP3 UGGT2 RCN3 | 7.90e-06 | 309 | 190 | 13 | int:TMEM106B |
| Interaction | PRKAR2B interactions | 8.76e-06 | 143 | 190 | 9 | int:PRKAR2B | |
| Interaction | ECT2 interactions | CLTCL1 HLA-C PRXL2B OTUB1 CD109 HNRNPA3 RPS16 OAT LARP1B HNRNPU ERLIN2 PPP3CA WDHD1 STRAP ANLN CLTC TJP2 GNAI2 MME GNAO1 UBE3C ARHGAP21 PHLDB2 | 1.11e-05 | 887 | 190 | 23 | int:ECT2 |
| Interaction | RHOC interactions | HLA-C ACTR10 SLITRK4 ARHGAP39 EZH2 ARHGAP1 IGF2R PPP3CA ANLN EPHA2 CLTC STON2 TJP2 GNAI2 IL1RAP PHLDB2 EPHA5 EPHA7 | 1.11e-05 | 584 | 190 | 18 | int:RHOC |
| Interaction | ARCN1 interactions | NR2C2 DSCAM COPZ1 OTUB1 EZH2 GSTP1 ANLN STIP1 MUSK EPHA5 EPHA7 | 1.13e-05 | 228 | 190 | 11 | int:ARCN1 |
| Interaction | ARHGAP1 interactions | RDX FIS1 DNAJC7 SERPINH1 ARHGAP1 ANLN CLTC LAMP3 DNAJC5 ARHGAP8 AKAP1 | 1.38e-05 | 233 | 190 | 11 | int:ARHGAP1 |
| Interaction | EED interactions | NR2C2 COPZ1 STAG1 ACTR10 OTUB1 HNRNPA3 NAPA RPS16 MCM3 CUBN DBT EZH1 EZH2 SERPINH1 WTAP HNRNPU TMEM11 ARHGAP1 NAA25 THADA ERLIN2 IGF2R ANLN RMDN1 CLTC STON2 VPS41 TJP2 GNAI2 UBE3C HCFC1 | 1.39e-05 | 1445 | 190 | 31 | int:EED |
| Interaction | EPHA10 interactions | 1.70e-05 | 86 | 190 | 7 | int:EPHA10 | |
| Interaction | HOOK1 interactions | KAT5 DBT PJA2 WDHD1 N4BP2 ZNF655 PRMT5 VPS41 PEX5 TJP2 UBE3C | 1.82e-05 | 240 | 190 | 11 | int:HOOK1 |
| Interaction | OCLN interactions | EPHB2 ABI1 RDX ARHGAP39 ARHGAP1 IGF2R CSNK2A1 EPHA2 CLTC LAMP3 TJP2 DNAJC5 UBE3C ARHGAP21 PHLDB2 EPHA7 | 2.22e-05 | 500 | 190 | 16 | int:OCLN |
| Interaction | FAF2 interactions | SEL1L ABCB7 PSEN1 HLA-C HLA-G OAT FIS1 SERPINH1 PJA2 ERLIN2 LAMP3 STIP1 UBE3C AKAP1 EPHA10 | 2.59e-05 | 451 | 190 | 15 | int:FAF2 |
| Interaction | HSPA4L interactions | NR2C2 SGTA NAPA RNF213 MCM3 DNAJC7 EDEM3 PPP3CA ANLN STIP1 EPHA10 | 2.65e-05 | 250 | 190 | 11 | int:HSPA4L |
| Interaction | RAB2A interactions | EPHB2 NR2C2 ABCB7 INPP5F EZH2 HNRNPU ARHGAP1 ERLIN2 IGF2R ANLN EPHA2 LAMP3 GNAI2 AKAP1 HCCS ARHGAP21 EPHA7 | 2.80e-05 | 567 | 190 | 17 | int:RAB2A |
| Interaction | CLINT1 interactions | 2.81e-05 | 207 | 190 | 10 | int:CLINT1 | |
| Interaction | SEC23A interactions | EPHB2 COG7 SGTA DYRK1A SERPINH1 THADA CLTC STIP1 MUSK EPHA5 EPHA7 | 3.18e-05 | 255 | 190 | 11 | int:SEC23A |
| Interaction | TP73 interactions | 3.33e-05 | 169 | 190 | 9 | int:TP73 | |
| Interaction | LRBA interactions | 3.48e-05 | 170 | 190 | 9 | int:LRBA | |
| Interaction | LOXL2 interactions | SEL1L RPS16 MCM3 OAT IDE TF PDIA3 HNRNPU GSTP1 ERLIN2 CLTC LRP1 STIP1 EPHA7 | 3.65e-05 | 410 | 190 | 14 | int:LOXL2 |
| Interaction | ACBD3 interactions | EPHB2 FIS1 HNRNPU EPHA2 LAMP3 TJP2 ZFHX3 STIP1 MUSK EPHA5 EPHA7 | 3.67e-05 | 259 | 190 | 11 | int:ACBD3 |
| Interaction | RAB11A interactions | NIBAN1 PSEN1 ACTR10 NAPA INPP5F EZH2 SERPINH1 SCYL2 ARHGAP1 KAT2B IGF2R EPHA2 CLTC LAMP3 LRP1 LRP4 DNAJC5 STIP1 MME GNAO1 AKAP1 | 3.92e-05 | 830 | 190 | 21 | int:RAB11A |
| Interaction | MTCH2 interactions | ABCB7 DNAJC7 SERPINH1 NDUFB10 HNRNPU ARHGAP1 ANLN CLTC PEX5 ARHGAP25 GNAI2 STIP1 AKAP1 HCCS | 3.95e-05 | 413 | 190 | 14 | int:MTCH2 |
| Interaction | ARF6 interactions | EPHB2 NR2C2 COPZ1 KAT2A EZH2 ARHGAP1 IGF2R ANLN EPHA2 CLTC LAMP3 TJP2 ZFHX3 GNAQ AKAP1 ARHGAP21 EPHA7 | 4.05e-05 | 584 | 190 | 17 | int:ARF6 |
| Interaction | PRKAR2A interactions | 4.20e-05 | 217 | 190 | 10 | int:PRKAR2A | |
| Interaction | HNRNPDL interactions | NR2C2 HNRNPA3 EZH2 SERPINH1 IFIT2 PDIA3 HNRNPU ARHGAP1 ANLN CSNK2A1 LRP1 STIP1 HCFC1 | 4.41e-05 | 364 | 190 | 13 | int:HNRNPDL |
| Interaction | CALD1 interactions | OTUB1 DYRK1A RDX OAT PDIA3 WTAP CSNK2A1 LRP1 TJP2 STIP1 PHLDB2 | 4.51e-05 | 265 | 190 | 11 | int:CALD1 |
| Interaction | SH3KBP1 interactions | EPHB2 HIVEP1 ITGA3 SERPINH1 WTAP PPP3CA ANLN CSNK2A1 CLTC TJP2 CSNK2A3 PHLDB2 | 4.69e-05 | 315 | 190 | 12 | int:SH3KBP1 |
| Interaction | DNAJA1 interactions | CLUAP1 HIVEP1 PSEN1 OTUB1 PPARG EZH2 DNAJC7 PDIA3 THADA STRAP ANLN PRMT5 CLTC DNAJC5 STIP1 AKAP1 | 4.78e-05 | 533 | 190 | 16 | int:DNAJA1 |
| Interaction | SNCA interactions | STAG1 DYRK1A TOR1A NAPA RPS16 RDX KAT2A INPP5F HNRNPU ARHGAP1 KAT2B PPP3CA CSNK2A1 CLTC DNAJC5 STIP1 GNAO1 HCFC1 ARHGAP21 | 4.96e-05 | 716 | 190 | 19 | int:SNCA |
| Interaction | FBXO6 interactions | SEL1L ATRN HLA-C CD109 MCM3 OAT ITGA3 SERPINH1 HEPH SCYL2 EDEM3 ERLIN2 IGF2R STRAP PRMT5 CLTC LAMP3 LRP1 UGGT2 | 5.06e-05 | 717 | 190 | 19 | int:FBXO6 |
| Interaction | CCDC8 interactions | NIBAN1 KAT5 HLA-C DYRK1A MCM3 SERPINH1 PDIA3 DICER1 HNRNPU IGF2R CSNK2A1 EPHA2 CLTC PEX5 DNAJC5 GNAI2 STIP1 PHLDB2 | 5.15e-05 | 656 | 190 | 18 | int:CCDC8 |
| Interaction | CNDP2 interactions | 5.29e-05 | 139 | 190 | 8 | int:CNDP2 | |
| Interaction | MAPT interactions | ABI1 PSEN1 COPZ1 STAG1 ACTR10 OTUB1 PSMB5 HNRNPA3 DYRK1A RPS16 SERPINH1 PDIA3 NDUFB10 HNRNPU GSTP1 ERLIN2 PPP3CA NAPB CSNK2A1 CLTC GNAI2 STIP1 GNAO1 GNAQ CSNK2A3 | 5.42e-05 | 1119 | 190 | 25 | int:MAPT |
| Interaction | CANX interactions | ATRN NR2C2 HLA-C CD109 TOR1A NAPA EZH2 SERPINH1 TF PDIA3 NDUFB10 F8 ARHGAP1 EDEM3 ERLIN2 IGF2R ANLN CSNK2A1 CLTC DPY19L4 LAMP3 LRP1 UGGT2 STIP1 AKAP1 EPHA10 SLC35A5 | 5.51e-05 | 1261 | 190 | 27 | int:CANX |
| Interaction | AP2B1 interactions | DSCAM DYRK1A EZH2 SCYL2 IGF2R ANLN N4BP2 EPHA2 CLTC STON2 PEX5 DNAJC5 STIP1 | 5.65e-05 | 373 | 190 | 13 | int:AP2B1 |
| Interaction | CAV1 interactions | EPHB2 HLA-C ARHGAP39 PPARG SERPINH1 PDIA3 ARHGAP1 IGF2R ANLN CSNK2A1 EPHA2 CLTC LAMP3 LRP1 DNAJC5 GNAI2 AKAP1 ARHGAP21 EPHA7 | 5.75e-05 | 724 | 190 | 19 | int:CAV1 |
| Interaction | MARCKS interactions | HLA-C RDX ARHGAP39 EZH2 PDIA3 HNRNPU SCYL2 ARHGAP1 IGF2R ANLN CSNK2A1 EPHA2 LAMP3 DNAJC5 AKAP1 CNOT3 EPHA7 | 5.78e-05 | 601 | 190 | 17 | int:MARCKS |
| Interaction | DNAJA2 interactions | CLUAP1 PSEN1 DSCAM SGTA TRMT11 EZH2 DNAJC7 IFIT2 WDR19 PJA2 ANLN N4BP2 PRMT5 DNAJC5 STIP1 AKAP1 | 5.83e-05 | 542 | 190 | 16 | int:DNAJA2 |
| Interaction | CHMP4B interactions | CLTCL1 CD109 HNRNPA3 NAPA RPS16 RDX MCM3 OAT EZH2 HNRNPU IGF2R PPP3CA ANLN CAPN7 CLTC TJP2 GNAI2 GNAO1 ARHGAP21 | 6.08e-05 | 727 | 190 | 19 | int:CHMP4B |
| Interaction | CAPZA2 interactions | NR2C2 CLTCL1 SGTA ACTR10 EZH2 WTAP STRAP ANLN CLTC STON2 GNAI2 ARHGAP21 CNOT3 PHLDB2 | 6.10e-05 | 430 | 190 | 14 | int:CAPZA2 |
| Interaction | AR interactions | NR2C2 HIVEP1 KAT5 OTUB1 PSMB5 NAPA RPS16 RNF213 MCM3 IDE EZH2 DNAJC7 SUV39H2 HNRNPU GRHL1 KAT2B ANLN CSNK2A1 CLTC ZFHX3 STIP1 MME HCFC1 | 6.33e-05 | 992 | 190 | 23 | int:AR |
| Interaction | EFNB2 interactions | 6.47e-05 | 143 | 190 | 8 | int:EFNB2 | |
| Interaction | RAC1 interactions | DOCK1 NR2C2 IL32 ABI1 HLA-C SLITRK4 RDX APLP2 ARHGAP39 ITGA3 GSTP1 ARHGAP1 IGF2R EPHA2 CLTC STON2 LRP4 GNAI2 ARHGAP8 IL1RAP ARHGAP21 PHLDB2 EPHA5 EPHA7 | 6.58e-05 | 1063 | 190 | 24 | int:RAC1 |
| Interaction | SEC22B interactions | CLUAP1 COPZ1 SGTA NAPA FIS1 EZH2 DNAJC7 SERPINH1 DICER1 NAPB LAMP3 DNAJC5 MUSK | 6.64e-05 | 379 | 190 | 13 | int:SEC22B |
| Interaction | CLTB interactions | 6.73e-05 | 185 | 190 | 9 | int:CLTB | |
| Interaction | ARF5 interactions | NR2C2 COPZ1 MCM3 EZH2 SERPINH1 IGF2R ANLN EPHA2 AKAP1 ARHGAP21 | 7.09e-05 | 231 | 190 | 10 | int:ARF5 |
| Interaction | EIF3H interactions | ABI1 RPS16 EZH2 HNRNPU SCYL2 ANLN CSNK2A1 PRMT5 CLTC STIP1 CSNK2A3 | 7.89e-05 | 282 | 190 | 11 | int:EIF3H |
| Interaction | SETSIP interactions | 8.29e-05 | 25 | 190 | 4 | int:SETSIP | |
| Interaction | FLOT2 interactions | RDX FIS1 EZH2 STAT4 ERLIN2 ANLN EPHA2 LAMP3 DNAJC5 MME EPHA5 | 8.67e-05 | 285 | 190 | 11 | int:FLOT2 |
| Interaction | EGLN3 interactions | SEL1L PSMF1 ABCB7 COPZ1 HLA-C INPP5K OTUB1 DYRK1A MCM3 ARHGAP39 DNAJC7 SERPINH1 NDUFB10 DICER1 PJA2 IGF2R WDHD1 N4BP2 CSNK2A1 ZNF655 PRMT5 GPN2 STIP1 AKAP1 HCFC1 ARHGAP21 CNOT3 | 8.73e-05 | 1296 | 190 | 27 | int:EGLN3 |
| Interaction | BAG2 interactions | NR2C2 CLUAP1 PSEN1 SGTA PIWIL1 OTUB1 PPARG DNAJC7 SCYL2 WDHD1 ANLN CLTC DNAJC5 STIP1 AKAP1 ARHGAP21 CNOT3 | 8.79e-05 | 622 | 190 | 17 | int:BAG2 |
| Interaction | STAT3 interactions | NR2C2 HIVEP1 KAT5 DSCAM IDE KAT2A EZH2 PDIA3 STAT4 KAT2B ZFHX3 STIP1 IL1RAP EPHA5 | 8.99e-05 | 446 | 190 | 14 | int:STAT3 |
| Interaction | AIMP2 interactions | NR2C2 ABI1 OTUB1 HNRNPA3 MCM3 DBT DNAJC7 PDIA3 HNRNPU GSTP1 ARHGAP1 ANLN CLTC STIP1 | 8.99e-05 | 446 | 190 | 14 | int:AIMP2 |
| Interaction | PTPN1 interactions | OTUB1 NAPA RNF213 APLP2 FIS1 ARHGAP39 EZH2 HNRNPU ARHGAP1 ERLIN2 ANLN CSNK2A1 LAMP3 PEX5 AKAP1 MUSK EPHA5 | 9.32e-05 | 625 | 190 | 17 | int:PTPN1 |
| Interaction | HLA-B interactions | 9.41e-05 | 239 | 190 | 10 | int:HLA-B | |
| Interaction | FSIP2 interactions | 9.73e-05 | 26 | 190 | 4 | int:FSIP2 | |
| Interaction | MYH9 interactions | SEL1L NR2C2 HIVEP1 CD109 OAT HMGCS2 EZH2 HNRNPU ANLN CSNK2A1 PRMT5 CLTC STON2 PEX5 GNAI2 MME UBE3C DNAH5 ARHGAP21 | 9.82e-05 | 754 | 190 | 19 | int:MYH9 |
| Interaction | H4C16 interactions | 9.93e-05 | 152 | 190 | 8 | int:H4C16 | |
| Interaction | PFN1 interactions | DOCK1 NR2C2 ABI1 RDX INPP5F EZH2 PDIA3 SCYL2 THADA ANLN N4BP2 CLTC TJP2 UGGT2 ARHGAP21 | 1.02e-04 | 509 | 190 | 15 | int:PFN1 |
| Interaction | TRIM37 interactions | RPGRIP1 KAT5 DSCAM HLA-C RPS16 RDX PPARG EZH2 PDIA3 HNRNPU SCYL2 ZNF610 ZNF655 CLTC LRP1 PEX5 PHLDB2 | 1.03e-04 | 630 | 190 | 17 | int:TRIM37 |
| Interaction | CTSB interactions | SEL1L DSC1 HLA-C EZH2 SERPINH1 PDIA3 GSTP1 ERLIN2 IGF2R UGGT2 | 1.04e-04 | 242 | 190 | 10 | int:CTSB |
| Interaction | BSG interactions | SEL1L CLUAP1 TTC28 COG7 OTUB1 NAPA RNF213 OAT ARHGAP1 ERLIN2 ANLN EPHA2 CLTC LAMP3 DNAJC5 GNAI2 EPHA5 | 1.05e-04 | 631 | 190 | 17 | int:BSG |
| Interaction | GRIN1 interactions | 1.09e-04 | 154 | 190 | 8 | int:GRIN1 | |
| Interaction | CLU interactions | CLUAP1 DSCAM DYRK1A TOR1A TF PDIA3 ADCYAP1R1 TENM3 LRP1 DNAJC5 | 1.15e-04 | 245 | 190 | 10 | int:CLU |
| Interaction | SNAP25 interactions | 1.16e-04 | 116 | 190 | 7 | int:SNAP25 | |
| Interaction | CTNNA1 interactions | PSEN1 HNRNPA3 DYRK1A SERPINH1 ANLN CSNK2A1 EPHA2 TJP2 DNAJC5 STIP1 ARHGAP21 EPHA7 | 1.18e-04 | 347 | 190 | 12 | int:CTNNA1 |
| Interaction | PKP4 interactions | 1.36e-04 | 159 | 190 | 8 | int:PKP4 | |
| Interaction | SSR3 interactions | 1.36e-04 | 159 | 190 | 8 | int:SSR3 | |
| Interaction | CDC37 interactions | EPHB2 NR2C2 HIVEP1 PSEN1 HNRNPA3 DNAJC7 EDEM3 ANLN CSNK2A1 EPHA2 ZNF655 PRMT5 STIP1 AKAP1 MUSK EPHA5 EPHA7 | 1.36e-04 | 645 | 190 | 17 | int:CDC37 |
| Interaction | MYO19 interactions | CLTCL1 ACTR10 FIS1 ANLN CLTC STON2 TJP2 AKAP1 ARHGAP21 PHLDB2 | 1.45e-04 | 252 | 190 | 10 | int:MYO19 |
| Interaction | DLD interactions | NR2C2 DSC1 COPZ1 OTUB1 MCM3 OAT ARHGAP39 DBT SERPINH1 TF NDUFB10 ZNF248 GSTP1 STRAP STIP1 | 1.46e-04 | 526 | 190 | 15 | int:DLD |
| Interaction | PIK3R1 interactions | EPHB2 ABI1 PSEN1 PSMB5 ARHGAP1 WDHD1 CSNK2A1 EPHA2 MME GNAQ IL1RAP EPHA5 EPHA7 | 1.53e-04 | 412 | 190 | 13 | int:PIK3R1 |
| Interaction | ALDH3A2 interactions | FIS1 EZH2 DNAJC7 THADA ANLN LAMP3 STIP1 MME AKAP1 MUSK EPHA5 | 1.53e-04 | 304 | 190 | 11 | int:ALDH3A2 |
| Interaction | PHF6 interactions | 1.54e-04 | 162 | 190 | 8 | int:PHF6 | |
| Interaction | NGB interactions | 1.61e-04 | 163 | 190 | 8 | int:NGB | |
| Interaction | ACBD5 interactions | 1.70e-04 | 209 | 190 | 9 | int:ACBD5 | |
| Interaction | RGS5 interactions | 1.70e-04 | 12 | 190 | 3 | int:RGS5 | |
| Interaction | OCIAD1 interactions | ABCB7 SGSM1 CLTCL1 KAT5 STAG1 COG7 RNF213 FIS1 SCYL2 ARHGAP1 THADA PEX5 AKAP1 | 1.80e-04 | 419 | 190 | 13 | int:OCIAD1 |
| Interaction | CUTA interactions | 1.83e-04 | 56 | 190 | 5 | int:CUTA | |
| Interaction | CAPZA1 interactions | SGTA ACTR10 OTUB1 PSMB5 RDX EZH2 ARHGAP1 STRAP ANLN CLTC AKAP1 CNOT3 | 1.93e-04 | 366 | 190 | 12 | int:CAPZA1 |
| Interaction | LIG1 interactions | 1.95e-04 | 126 | 190 | 7 | int:LIG1 | |
| Interaction | TXNRD2 interactions | 1.99e-04 | 57 | 190 | 5 | int:TXNRD2 | |
| Interaction | HSPA4 interactions | NR2C2 SGTA OTUB1 RDX EZH2 DNAJC7 KAT2B ERLIN2 ANLN CSNK2A1 EPHA2 CLTC DNAJC5 STIP1 MME AKAP1 HCFC1 | 2.02e-04 | 667 | 190 | 17 | int:HSPA4 |
| Interaction | VAT1 interactions | 2.04e-04 | 127 | 190 | 7 | int:VAT1 | |
| Interaction | PICALM interactions | CLTCL1 DYRK1A ANLN EPHA2 CLTC STON2 LAMP3 DNAJC5 STIP1 EPHA5 | 2.05e-04 | 263 | 190 | 10 | int:PICALM |
| Interaction | USP48 interactions | OTUB1 HNRNPA3 RNF213 MCM3 FIS1 SERPINH1 TF PDIA3 HNRNPU GSTP1 NAPB CSNK2A1 CLTC DNAJC5 GNAI2 STIP1 GNAO1 | 2.06e-04 | 668 | 190 | 17 | int:USP48 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | SPAG1 TTC24 TTC28 SGTA FIS1 DNAJC7 IFIT2 TTC7B PEX5 STIP1 CFAP46 | 6.53e-10 | 115 | 130 | 11 | 769 |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.38e-08 | 14 | 130 | 5 | 1095 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.91e-05 | 50 | 130 | 5 | 721 | |
| GeneFamily | ATAC complex | 9.86e-05 | 13 | 130 | 3 | 1058 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.55e-04 | 15 | 130 | 3 | 1296 | |
| GeneFamily | Fibronectin type III domain containing | 1.58e-04 | 160 | 130 | 7 | 555 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.29e-04 | 17 | 130 | 3 | 486 | |
| GeneFamily | Sterile alpha motif domain containing | 4.32e-04 | 88 | 130 | 5 | 760 | |
| GeneFamily | Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2 | 7.55e-04 | 6 | 130 | 2 | 1347 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.05e-03 | 7 | 130 | 2 | 1299 | |
| GeneFamily | Argonaute/PIWI family | 1.40e-03 | 8 | 130 | 2 | 408 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.85e-03 | 34 | 130 | 3 | 487 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.40e-03 | 42 | 130 | 3 | 602 | |
| GeneFamily | Low density lipoprotein receptors | 3.80e-03 | 13 | 130 | 2 | 634 | |
| GeneFamily | Cystatins, type 2 | 5.76e-03 | 16 | 130 | 2 | 965 | |
| GeneFamily | Dyneins, axonemal | 6.50e-03 | 17 | 130 | 2 | 536 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 6.50e-03 | 17 | 130 | 2 | 1059 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | TBC1D19 EPHB2 IL32 PSMF1 HIVEP1 STARD4 HLA-C HLA-G IFI44 APLP2 FIS1 ARHGAP39 HIVEP3 IL1RAPL1 TTC7B ADAMTS6 LAMP3 C1R ZFHX3 GNAQ ARHGAP21 PHLDB2 EPHA7 | 1.87e-06 | 1033 | 190 | 23 | M4196 |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN | 2.16e-06 | 200 | 190 | 10 | M7646 | |
| Coexpression | GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.46e-06 | 165 | 190 | 9 | M9094 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | SEL1L ATRN HLA-C CD109 HLA-G APLP2 ITGA3 PDIA3 P2RX4 LRP1 C1R AKAP1 CNOT3 RCN3 | 9.32e-06 | 470 | 190 | 14 | MM1053 |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | NIBAN1 PRXL2B IFI44 STAT4 HIVEP3 ZFHX3 ARHGAP25 ST8SIA4 CDCA7L | 1.57e-05 | 199 | 190 | 9 | M7491 |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 1.57e-05 | 199 | 190 | 9 | M7619 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 DOCK1 ATRN ABI1 HIVEP1 STAG1 TTC28 DYRK1A RDX INPP5F DICER1 PJA2 IGF2R WDHD1 CSNK2A1 TJP2 ZFHX3 GNAQ IL1RAP | 1.62e-05 | 856 | 190 | 19 | M4500 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | PSMF1 ABI1 STAG1 ACTR10 HNRNPA3 TRMT11 RDX IDE PJA2 CAPN7 PCMTD2 GNAQ SLC35A5 | 1.64e-05 | 429 | 190 | 13 | M29 |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 1.64e-05 | 200 | 190 | 9 | M9458 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 1.64e-05 | 200 | 190 | 9 | M7289 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 1.64e-05 | 200 | 190 | 9 | M3635 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING | 5.07e-05 | 231 | 190 | 9 | MM3741 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | TTC28 ASAH2 IFI44 GRIK1 SERPINH1 STAT4 IGF2R P2RX4 TENM3 LRP4 C1R ETNK1 GNAQ PHLDB2 EPHA5 EPHA7 | 7.78e-05 | 721 | 190 | 16 | M1999 |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED | 7.86e-05 | 12 | 190 | 3 | M47998 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP | 1.07e-04 | 199 | 190 | 8 | M8035 | |
| Coexpression | GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP | 1.07e-04 | 199 | 190 | 8 | M8462 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_UP | 1.07e-04 | 199 | 190 | 8 | M5145 | |
| Coexpression | GSE7460_CD8_TCELL_VS_TREG_ACT_DN | 1.07e-04 | 199 | 190 | 8 | M5684 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 1.11e-04 | 200 | 190 | 8 | M9586 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 1.11e-04 | 200 | 190 | 8 | M7322 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.11e-04 | 200 | 190 | 8 | M7168 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.11e-04 | 200 | 190 | 8 | M78 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN | 1.11e-04 | 200 | 190 | 8 | M7644 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 1.11e-04 | 200 | 190 | 8 | M5913 | |
| Coexpression | GSE7852_LN_VS_FAT_TREG_UP | 1.11e-04 | 200 | 190 | 8 | M5739 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN | 1.11e-04 | 200 | 190 | 8 | M5606 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | SEL1L ATRN CD109 APLP2 ITGA3 PDIA3 P2RX4 LRP1 C1R AKAP1 CNOT3 RCN3 | 1.36e-04 | 457 | 190 | 12 | M1613 |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 1.73e-04 | 160 | 190 | 7 | M11011 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 1.73e-04 | 160 | 190 | 7 | M8664 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.13e-07 | 173 | 190 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 182 | 190 | 8 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 192 | 190 | 8 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.92e-06 | 194 | 190 | 8 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-06 | 197 | 190 | 8 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.18e-06 | 138 | 190 | 7 | 35880e23ef317862891b54ac6a2265ca03b1d12a | |
| ToppCell | NS-critical-LOC|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-06 | 198 | 190 | 8 | ff9b9065f5d91a7aff99121bddc3e86f6b1c8a8d | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.14e-06 | 152 | 190 | 7 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 178 | 190 | 7 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 179 | 190 | 7 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 182 | 190 | 7 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 182 | 190 | 7 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 185 | 190 | 7 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.55e-05 | 186 | 190 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 188 | 190 | 7 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.66e-05 | 188 | 190 | 7 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 126 | 190 | 6 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 190 | 190 | 7 | 92710caaff05123cf8e909319d7ac441d9b31a66 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.83e-05 | 191 | 190 | 7 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-05 | 192 | 190 | 7 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.03e-05 | 194 | 190 | 7 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 194 | 190 | 7 | 46e522ca59db545d1eb0c27cd4361f19d4f8f762 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.03e-05 | 194 | 190 | 7 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.10e-05 | 195 | 190 | 7 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 2.10e-05 | 195 | 190 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.10e-05 | 195 | 190 | 7 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 2.10e-05 | 195 | 190 | 7 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-05 | 195 | 190 | 7 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.17e-05 | 196 | 190 | 7 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 2.24e-05 | 197 | 190 | 7 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 197 | 190 | 7 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 2.24e-05 | 197 | 190 | 7 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.31e-05 | 198 | 190 | 7 | 374d7a24e00cd3f435ca980123ab3c6a441c9ad5 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.31e-05 | 198 | 190 | 7 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.39e-05 | 199 | 190 | 7 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 190 | 7 | 019340e8b4b4944a49e14fdec7ce2954cbb8ba2e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 190 | 7 | b6f21f5cc137eddf6ba90e81cae791b57d88d9d7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.47e-05 | 200 | 190 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.75e-05 | 145 | 190 | 6 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 6.26e-05 | 159 | 190 | 6 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 6.26e-05 | 159 | 190 | 6 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.26e-05 | 159 | 190 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 162 | 190 | 6 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 162 | 190 | 6 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 162 | 190 | 6 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 162 | 190 | 6 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 164 | 190 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 164 | 190 | 6 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.94e-05 | 166 | 190 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.94e-05 | 166 | 190 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 168 | 190 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 168 | 190 | 6 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 168 | 190 | 6 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 168 | 190 | 6 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 169 | 190 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 169 | 190 | 6 | f6a6d2f614d60395ad9b867ff1cf59eba72b04ce | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 169 | 190 | 6 | df2c9c706bfc9db2bc5726602a49f5f5a94e9481 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.06e-05 | 170 | 190 | 6 | 49fc45d8a5c3ad89d1649fa46d7a285891379392 | |
| ToppCell | Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.97e-05 | 173 | 190 | 6 | a112da5b0ab6e1f13d1a7dfa72c67c9a95fa9243 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 175 | 190 | 6 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.10e-04 | 176 | 190 | 6 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 177 | 190 | 6 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 179 | 190 | 6 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 179 | 190 | 6 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 179 | 190 | 6 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 180 | 190 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 180 | 190 | 6 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 180 | 190 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-04 | 180 | 190 | 6 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 180 | 190 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 181 | 190 | 6 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 181 | 190 | 6 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.28e-04 | 181 | 190 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-04 | 182 | 190 | 6 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 182 | 190 | 6 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.36e-04 | 183 | 190 | 6 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.40e-04 | 184 | 190 | 6 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.40e-04 | 184 | 190 | 6 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 184 | 190 | 6 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.44e-04 | 185 | 190 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-04 | 185 | 190 | 6 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.44e-04 | 185 | 190 | 6 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.44e-04 | 185 | 190 | 6 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.44e-04 | 185 | 190 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 185 | 190 | 6 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 190 | 6 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 190 | 6 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.48e-04 | 186 | 190 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 190 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 190 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.52e-04 | 187 | 190 | 6 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 190 | 6 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 187 | 190 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 190 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 190 | 6 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| Drug | DHBT | 7.13e-07 | 119 | 190 | 9 | CID000001855 | |
| Drug | 4-toluidine | ATRN HIVEP1 COPZ1 TTC28 ASAH2 PRXL2B RDX OAT HMGCS2 GSTP1 IGF2R ZNF655 LRP1 C1R | 1.41e-06 | 347 | 190 | 14 | ctd:C029370 |
| Drug | AC1OAR8J | 2.27e-06 | 4 | 190 | 3 | CID006834124 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 7.42e-08 | 57 | 187 | 7 | DOID:10652 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.09e-05 | 264 | 187 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | metabolite measurement, body weight gain | 5.28e-05 | 12 | 187 | 3 | EFO_0004566, EFO_0004725 | |
| Disease | serum gamma-glutamyl transferase measurement | ATRN CLUAP1 BRIP1 SGSM1 PSEN1 STAG1 DYRK1A PPARG KAT2B THADA P2RX4 PTCD1 EPHA2 GNAI2 KLHDC7A ARHGAP21 CDCA7L | 7.79e-05 | 914 | 187 | 17 | EFO_0004532 |
| Disease | bitter beverage consumption measurement | 1.45e-04 | 42 | 187 | 4 | EFO_0010089 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.51e-04 | 239 | 187 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | Malignant neoplasm of prostate | EPHB2 SLC26A4 PCDH11Y HAO1 EZH2 PDIA3 ADAM28 GSTP1 IGF2R PPP3CA ZFHX3 MME CNOT3 | 1.65e-04 | 616 | 187 | 13 | C0376358 |
| Disease | upper aerodigestive tract neoplasm | 1.84e-04 | 246 | 187 | 8 | EFO_0004284 | |
| Disease | Nerve Degeneration | 1.89e-04 | 83 | 187 | 5 | C0027746 | |
| Disease | coronary artery disease | ANKRD31 CLTCL1 DSCAM STAG1 HLA-C CD109 RNF213 KAT2A ALS2CL SERPINH1 NAA25 THADA IGF2R LRP1 C1R GNAI2 GNAO1 ST8SIA4 ARHGAP21 | 2.24e-04 | 1194 | 187 | 19 | EFO_0001645 |
| Disease | prostate carcinoma in situ (biomarker_via_orthology) | 2.38e-04 | 4 | 187 | 2 | DOID:8634 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 3.21e-04 | 93 | 187 | 5 | C1535926 | |
| Disease | Down syndrome (is_marker_for) | 3.53e-04 | 22 | 187 | 3 | DOID:14250 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.53e-04 | 22 | 187 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | irritable bowel syndrome (implicated_via_orthology) | 3.95e-04 | 5 | 187 | 2 | DOID:9778 (implicated_via_orthology) | |
| Disease | myocardial infarction | 4.19e-04 | 350 | 187 | 9 | EFO_0000612 | |
| Disease | Acute Confusional Senile Dementia | 4.28e-04 | 99 | 187 | 5 | C0546126 | |
| Disease | Alzheimer Disease, Late Onset | 4.28e-04 | 99 | 187 | 5 | C0494463 | |
| Disease | Alzheimer's Disease, Focal Onset | 4.28e-04 | 99 | 187 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 4.28e-04 | 99 | 187 | 5 | C0750901 | |
| Disease | Presenile dementia | 4.28e-04 | 99 | 187 | 5 | C0011265 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.46e-04 | 153 | 187 | 6 | EFO_0004611, EFO_0020944 | |
| Disease | Familial Alzheimer Disease (FAD) | 4.48e-04 | 100 | 187 | 5 | C0276496 | |
| Disease | drug-induced liver injury | 4.60e-04 | 24 | 187 | 3 | EFO_0004228 | |
| Disease | Alzheimer's Disease | 4.69e-04 | 101 | 187 | 5 | C0002395 | |
| Disease | colorectal cancer (is_marker_for) | 5.12e-04 | 157 | 187 | 6 | DOID:9256 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | BRIP1 INPP5K CD109 TRMT11 CUBN EZH2 ALS2CL SUV39H2 STAT4 GSTP1 NAA25 IL1RAPL2 N4BP2 CST4 GNAI2 MME KLHDC7A | 5.12e-04 | 1074 | 187 | 17 | C0006142 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 5.42e-04 | 59 | 187 | 4 | EFO_0001663, MONDO_0005148 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.60e-04 | 222 | 187 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 5.89e-04 | 6 | 187 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | Paratuberculosis | 5.89e-04 | 6 | 187 | 2 | C0030524 | |
| Disease | Prostatic Neoplasms | SLC26A4 PCDH11Y HAO1 EZH2 PDIA3 ADAM28 GSTP1 IGF2R PPP3CA ZFHX3 MME CNOT3 | 6.00e-04 | 616 | 187 | 12 | C0033578 |
| Disease | congestive heart failure (is_implicated_in) | 6.55e-04 | 27 | 187 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 7.05e-04 | 301 | 187 | 8 | DOID:684 (is_marker_for) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 8.22e-04 | 7 | 187 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 8.29e-04 | 66 | 187 | 4 | DOID:3459 (is_marker_for) | |
| Disease | factor XI measurement, coronary artery disease | 8.47e-04 | 115 | 187 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 9.79e-04 | 69 | 187 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | bitter non-alcoholic beverage consumption measurement | 1.09e-03 | 32 | 187 | 3 | EFO_0010093 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.09e-03 | 8 | 187 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 1.09e-03 | 8 | 187 | 2 | OBA_2045153 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 1.09e-03 | 8 | 187 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 1.09e-03 | 8 | 187 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | binge eating | 1.09e-03 | 8 | 187 | 2 | EFO_0005924 | |
| Disease | cystatin-SA measurement | 1.09e-03 | 8 | 187 | 2 | EFO_0008105 | |
| Disease | cystatin-SN measurement | 1.40e-03 | 9 | 187 | 2 | EFO_0008106 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.57e-03 | 132 | 187 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | citrate measurement | 1.62e-03 | 79 | 187 | 4 | EFO_0010114 | |
| Disease | Asthma | 1.70e-03 | 80 | 187 | 4 | C0004096 | |
| Disease | complement C1q subcomponent subunit C measurement | 1.74e-03 | 10 | 187 | 2 | EFO_0801492 | |
| Disease | Epilepsy, Cryptogenic | 1.86e-03 | 82 | 187 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.86e-03 | 82 | 187 | 4 | C0751111 | |
| Disease | Aura | 1.86e-03 | 82 | 187 | 4 | C0236018 | |
| Disease | response to glucocorticoid, osteonecrosis | 1.94e-03 | 39 | 187 | 3 | EFO_0004259, GO_0051384 | |
| Disease | neuroticism measurement | HIVEP1 STAG1 DYRK1A HPSE2 GRIK1 IL1RAPL1 GRHL1 TENM3 VPS41 LRP4 GNAI2 GNAO1 ST8SIA4 CDCA7L | 2.06e-03 | 909 | 187 | 14 | EFO_0007660 |
| Disease | Moyamoya disease | 2.08e-03 | 40 | 187 | 3 | MONDO_0016820 | |
| Disease | urate measurement, bone density | NR2C2 DSCAM TTC28 SGTA THAP9 SCYL2 CSNK2A1 GALNT9 UGGT2 ARHGAP25 SEL1L2 | 2.08e-03 | 619 | 187 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Liver neoplasms | 2.16e-03 | 142 | 187 | 5 | C0023903 | |
| Disease | Malignant neoplasm of liver | 2.16e-03 | 142 | 187 | 5 | C0345904 | |
| Disease | kidney disease (implicated_via_orthology) | 2.24e-03 | 41 | 187 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma | 2.24e-03 | 41 | 187 | 3 | EFO_0000182 | |
| Disease | stroke | 2.29e-03 | 144 | 187 | 5 | EFO_0000712 | |
| Disease | platelet-to-lymphocyte ratio | 2.31e-03 | 363 | 187 | 8 | EFO_0008446 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.57e-03 | 215 | 187 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | obesity (implicated_via_orthology) | 2.57e-03 | 215 | 187 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 2.92e-03 | 45 | 187 | 3 | EFO_0803319 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.98e-03 | 13 | 187 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 2.98e-03 | 13 | 187 | 2 | OBA_2045159 | |
| Disease | autoimmune hepatitis (is_implicated_in) | 2.98e-03 | 13 | 187 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | alcohol and nicotine codependence | 2.98e-03 | 13 | 187 | 2 | EFO_0004776 | |
| Disease | worry measurement | 3.06e-03 | 154 | 187 | 5 | EFO_0009589 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.21e-03 | 225 | 187 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 3.35e-03 | 227 | 187 | 6 | EFO_0020946 | |
| Disease | neuroticism measurement, cognitive function measurement | HIVEP1 DSCAM STAG1 PCDHA5 TENM3 N4BP2 ZNF655 ZFHX3 GNAO1 ST8SIA4 | 3.43e-03 | 566 | 187 | 10 | EFO_0007660, EFO_0008354 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 3.46e-03 | 14 | 187 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | diacylglycerol 38:4 measurement | 3.46e-03 | 14 | 187 | 2 | EFO_0020066 | |
| Disease | trimethylamine-N-oxide measurement | 3.46e-03 | 14 | 187 | 2 | EFO_0010541 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 3.46e-03 | 14 | 187 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | congenital left-sided heart lesions | 3.51e-03 | 48 | 187 | 3 | EFO_0005938 | |
| Disease | apolipoprotein B measurement | ANKRD31 PSEN1 STAG1 AGPAT4 HLA-G PPARG THADA IGF2R ZFHX3 PCMTD2 MUSK | 3.51e-03 | 663 | 187 | 11 | EFO_0004615 |
| Disease | hearing impairment | 3.55e-03 | 98 | 187 | 4 | C1384666 | |
| Disease | Vitiligo | 3.95e-03 | 101 | 187 | 4 | EFO_0004208 | |
| Disease | cryptococcosis | 3.97e-03 | 15 | 187 | 2 | EFO_0007229 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.97e-03 | 15 | 187 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | forehead morphology measurement | 3.97e-03 | 15 | 187 | 2 | EFO_0007844 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.17e-03 | 51 | 187 | 3 | cv:CN043650 | |
| Disease | chronotype measurement | DOCK1 HIVEP1 COPZ1 TTC28 EZH2 IL1RAPL1 ARHGAP1 NAA25 PPP3CA WDHD1 GNAI2 GNAO1 EPHA5 | 4.26e-03 | 882 | 187 | 13 | EFO_0008328 |
| Disease | Schizophrenia | HLA-C HNRNPA3 GRIK1 IDE ALS2CL TF DICER1 ADCYAP1R1 GSTP1 ARHGAP1 STON2 LRP1 GNAO1 | 4.30e-03 | 883 | 187 | 13 | C0036341 |
| Disease | C-reactive protein measurement | RPGRIP1 KAT5 HLA-C DYRK1A TRMT11 P2RX4 PTCD1 ZNF655 DNAH17 DNAJC5 PCMTD2 GNAI2 GNAO1 ARHGAP21 MUSK EPHA7 | 4.41e-03 | 1206 | 187 | 16 | EFO_0004458 |
| Disease | glucose metabolism measurement, age-related hearing impairment | 4.41e-03 | 52 | 187 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | complement C4 measurement | 4.41e-03 | 52 | 187 | 3 | EFO_0004984 | |
| Disease | Influenza | 4.41e-03 | 52 | 187 | 3 | C0021400 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 4.52e-03 | 16 | 187 | 2 | EFO_0007633, HP_0012235 | |
| Disease | thyroid volume | 4.52e-03 | 16 | 187 | 2 | EFO_0004865 | |
| Disease | migraine without aura, susceptibility to, 4 | 4.52e-03 | 16 | 187 | 2 | MONDO_0011847 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.54e-03 | 169 | 187 | 5 | DOID:3908 (is_marker_for) | |
| Disease | mean arterial pressure | 4.74e-03 | 499 | 187 | 9 | EFO_0006340 | |
| Disease | Renal Insufficiency | 5.10e-03 | 17 | 187 | 2 | C1565489 | |
| Disease | cystatin-D measurement | 5.10e-03 | 17 | 187 | 2 | EFO_0008103 | |
| Disease | sphingomyelin 14:0 measurement | 5.10e-03 | 17 | 187 | 2 | EFO_0010390 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSTDEVYKGYFQEGL | 426 | Q60I27 | |
| TNEVEIRYVDYGGYK | 786 | Q92667 | |
| EYNYLQKDNPAEYAS | 531 | P83436 | |
| IEYYLVLDNGEFKRY | 206 | Q9UKQ2 | |
| EYEIKYFEKDQETSY | 501 | P54756 | |
| DNKDLFYINLYPDYA | 141 | P39086 | |
| EEQKTAYYLEAYGLA | 1801 | Q8IYW2 | |
| NYIEKVVAIYDYTKD | 446 | Q8IZP0 | |
| YLKTDNYINGEYFAT | 391 | P23109 | |
| IDYYDGGEVNKDYQF | 226 | P53701 | |
| KERKVYNDGYDDDNY | 131 | Q13627 | |
| NDKALYYFLEIASAY | 1081 | Q96PN6 | |
| ETFAEYYKTKYNLDL | 966 | Q9UPY3 | |
| YKGFLAYYQAVDLDE | 131 | P00736 | |
| ALKVNLSDYIGEYSY | 511 | Q86XH1 | |
| QYNINTEELYSYLKE | 56 | Q9NZ32 | |
| YIALKSEGDDYYING | 756 | Q9UKP5 | |
| VKNYYLNTYEGLVEL | 391 | Q7Z4T9 | |
| YYLEGTKAQYLAAKA | 676 | O75175 | |
| KDGYVQVEEYIADLY | 216 | Q96D15 | |
| DIDGYEYAYLKAIVL | 486 | P49116 | |
| KYKYVEDYEQGLASE | 371 | Q99571 | |
| KDYEIYRDYSADGQL | 181 | Q9C0H5 | |
| LTYADEYAIGYFKKQ | 611 | Q92830 | |
| YQLSDSTKYYLNDLD | 151 | P50148 | |
| ASYAVQAKYGDYNKE | 126 | P35241 | |
| AANTFIEDSGYKEYY | 411 | Q7Z5J8 | |
| EVVEDRDYYYDTFKG | 266 | Q06481 | |
| LFINKEDVYEYYQKD | 671 | Q8N7Z5 | |
| GYEQYAYDGKDYLAL | 136 | P17693 | |
| GVIKKLYYNLDDIAY | 116 | P11182 | |
| VEYGKYSNDLYELQA | 101 | P51610 | |
| YGKLAFNLDYYTEVL | 186 | Q9H9Y4 | |
| LTYADEYAIGYFKKQ | 606 | Q92831 | |
| DGKEYDIYVSYARNA | 401 | Q9NPH3 | |
| EGKYEEYGYNAQLSD | 111 | Q9HCQ5 | |
| AYLDYIEVVDYEGKG | 386 | Q07954 | |
| DAANYYYLIILKAGA | 826 | Q9NQW6 | |
| YASYLLEQEKNKGYL | 321 | Q9NR71 | |
| YGYISNVQEYDLDKN | 471 | O75882 | |
| YEYLLKAYVLLGDDS | 296 | Q9BZQ6 | |
| NYYKGQYILTLSEDI | 466 | Q92993 | |
| ENVYDFYKPNLASEY | 236 | P54868 | |
| LQYYEKELSEYNATA | 471 | P29323 | |
| YRYSQADALKYVGIE | 726 | Q15910 | |
| YLAVGNYRLKEYEKA | 76 | Q9Y3D6 | |
| GYDQSAYDGKDYIAL | 136 | P10321 | |
| YYLEEFKENAYKDLA | 41 | Q9NV79 | |
| EYSYKDPEDQGNLYI | 236 | P26006 | |
| DNKDYDAYLSYTKVD | 401 | Q9NZN1 | |
| DYDDLTSATYDKGYQ | 311 | P50542 | |
| KAYQDRYQDLGAYSS | 131 | O96000 | |
| GYFEYIEENKYSRAK | 256 | Q00839 | |
| KSIYDYYRSGANDEE | 21 | Q9UJM8 | |
| EYLELNYKEDEYFEN | 496 | P08473 | |
| NDGDRLFAKYYDDTY | 21 | P61923 | |
| KDEESYYISEVGAYL | 296 | Q9UQV4 | |
| DKNTGDYYEDSYEDI | 731 | P00451 | |
| AKFYGYDNVKEYLES | 431 | Q96GN5 | |
| NDTEYEIRYYEKGQS | 486 | Q5JZY3 | |
| IKVNGELDYEDYNSY | 301 | Q9Y5H7 | |
| YDKYGSLGLYVAEQF | 76 | Q9H3Z4 | |
| DYYLKNYEDDIVRSD | 141 | Q8WWQ2 | |
| GVITEYEIKYYEKDQ | 471 | Q15375 | |
| SETGDQDYYYLSVKA | 141 | P41586 | |
| YDIVKNYTADYDKAL | 101 | O94905 | |
| DVEDTAAIQGYKLYY | 641 | Q2VWP7 | |
| AAIQGYKLYYKEEGQ | 646 | Q2VWP7 | |
| DELLQVYYDAIKYKG | 736 | Q9BX63 | |
| SIDATYAKQYEEFYV | 86 | P25205 | |
| YAKQYEEFYVGLEGS | 91 | P25205 | |
| VLYKEYAEDDNIYQQ | 56 | Q96FW1 | |
| LYDYVKLYDGDSENA | 3216 | O60494 | |
| LTKDYIDGVYDNAEY | 646 | Q6YHK3 | |
| TEDLYGYIDKYNIEL | 251 | Q8NEV1 | |
| FKEGYLETVAAYYEE | 96 | P24001 | |
| IGAYAEESYQEGKYA | 61 | Q8TCB0 | |
| DSAAALGLLYDYYKV | 56 | Q9NZI5 | |
| GDEAISEYKSVIYYQ | 471 | Q14185 | |
| YSEAVFYYKEAAQAL | 26 | Q9Y6W3 | |
| NLDYKGYHEYIDENL | 4131 | Q9UFH2 | |
| KETFNLYYAESDLDY | 116 | P29317 | |
| YTYDEYKKGYLDQAS | 646 | P25067 | |
| YKVGLRDVNDYVSYA | 366 | Q9BT40 | |
| AEDIYKILTSYKANY | 626 | Q7Z388 | |
| AISEYNKVINKDEYY | 51 | P28325 | |
| SLIYTNYEAGKDDYV | 106 | P09211 | |
| AYELFAKGYEDYLQS | 296 | O14744 | |
| TEDLYDYIDKYNIEL | 251 | P68400 | |
| LADQYEDAEYYFQKE | 346 | P09913 | |
| LYYTEADYEDDSKIA | 651 | Q8NA54 | |
| AFKEGNYKLAYELYT | 266 | Q99615 | |
| NYKLAYELYTEALGI | 271 | Q99615 | |
| DREKYEQFALYGYAT | 201 | Q08554 | |
| KGKVYDYYVESTSQA | 286 | Q5VTJ3 | |
| YLELLKDSLNEYAYA | 596 | P14735 | |
| KQGDVQFIDYEYSGY | 321 | Q9HBU6 | |
| KQYEAYVQALEGKYT | 31 | Q15007 | |
| YDYEAIALNKNEYVS | 41 | O75715 | |
| AISEYNKATEDEYYR | 51 | P01036 | |
| VAYYDDEVDKVNQYQ | 651 | Q9Y2H2 | |
| YLDVYNNKAAVLKYE | 311 | Q08209 | |
| TYEVYKYAARGLYEE | 3876 | Q8TE73 | |
| NKDLYVLRYEYKDGS | 61 | Q92530 | |
| AKVINDGLYYYEQDL | 481 | Q659C4 | |
| ENAAYLDYESTKEYA | 451 | Q9BZA8 | |
| AKEYGDYFVVEYRDQ | 4321 | Q685J3 | |
| DGSEVSFLEYYRKQY | 336 | Q96J94 | |
| LYIKDVQNEDGLYNY | 181 | O60469 | |
| SYISDGKEYLFYLNV | 351 | P11717 | |
| YFAGELYLDESKQLY | 86 | Q8TBF2 | |
| ENLEYLQADYNLIKY | 131 | Q8IW52 | |
| SYTEKDKQAYLEAAY | 226 | Q16831 | |
| QYGLEKYYLDVLVSD | 276 | Q7Z4G4 | |
| EGNLDQKSYVIDYYL | 536 | Q6YHU6 | |
| DENIKQVYVEYKFYD | 1136 | Q96KN7 | |
| YITNQAAVYFEKGDY | 261 | P31948 | |
| YLGEVFKTYNVAVDY | 181 | P49768 | |
| YYKKALELDPDNETY | 181 | O43765 | |
| YKDGDYNAAVIQYLL | 566 | Q9UBV2 | |
| DGKEITFLEYYSKNY | 446 | Q8TC59 | |
| EYDQAKALIYYTFGS | 196 | Q5TEA6 | |
| NDDNKEYDAYLSYTK | 396 | Q9NP60 | |
| QGKDLLIAYYDVDYE | 256 | P30101 | |
| LIAYYDVDYEKNAKG | 261 | P30101 | |
| YTGANKYDEAASYIQ | 291 | P04899 | |
| EYQLNDSAKYYLDSL | 146 | P09471 | |
| GVFYEKDYEGTVYND | 486 | Q9BQS7 | |
| ADYKYDLKLQEYQSA | 91 | P37231 | |
| DLTDKLVASYYEDYA | 51 | Q8WXC3 | |
| GYLKHTLDQYVESDY | 106 | Q07960 | |
| GLYNYYDDEKEKLQI | 241 | P50454 | |
| LGLESLEYLQADYNY | 131 | Q9H156 | |
| ALVAYYQKYVDEASK | 91 | P62249 | |
| DLNGKAVKYHYYDDL | 306 | Q92187 | |
| DYKLYDVETKYGLLQ | 146 | Q6P3W7 | |
| GVFIAYDDDKVYTYV | 571 | Q8NEZ3 | |
| FSEAAQLYEKGLYYD | 856 | Q8NEZ3 | |
| QLYEKGLYYDKAASV | 861 | Q8NEZ3 | |
| AIAHYEQSADYYKGE | 141 | P54920 | |
| YAALLEQYQKAIDIY | 171 | P54920 | |
| KGVIYFQAIEEVYYD | 1186 | Q86SQ0 | |
| EEIFYYYDTNTGKEG | 451 | Q6UX06 | |
| YNNVLGEYEEYITKL | 116 | P04181 | |
| VKLTDTGYLQLYYEQ | 451 | Q8WXE9 | |
| KLYKYDYNSGEELES | 246 | Q9Y3F4 | |
| YEAQRYDGFLKTYET | 351 | O75027 | |
| LVFLYDKYEEYDNAI | 1361 | Q00610 | |
| YEEGMYEAAKLLYSN | 1206 | P53675 | |
| LVFLYDKYEEYDNAV | 1361 | P53675 | |
| YDTYLEKFQNLTYLE | 256 | Q96AJ1 | |
| QEEKAYIRGKSYEYE | 191 | Q8N9Z0 | |
| YDTYQEFEEAYILKE | 51 | P01242 | |
| KYVIYNGESFEYEFI | 451 | Q63HN8 | |
| QNKEESYDFSKSYEY | 1001 | Q9UDY2 | |
| LGQYDQALKYYKEAL | 366 | A2A3L6 | |
| FLDYYDLVDGVSYQK | 186 | O14656 | |
| EYELEQALEAQYKYI | 46 | P17152 | |
| YEKYLGEEYVKAVGN | 666 | P02787 | |
| DYAVESYENKEAYQR | 96 | Q9BZQ8 | |
| SQLYLDDLFSDYYDK | 266 | Q0ZLH3 | |
| YATKYDYTIDGNQEF | 371 | O43511 | |
| LVKYSANEENKYDYL | 36 | Q9BS91 | |
| KAYYNLETRYKFQDE | 636 | Q9H5L6 | |
| DYLYESGETEKLYQL | 91 | Q96DB5 | |
| TKYLEDLQDEFDYRY | 161 | Q14765 | |
| YLAKNGYEYEESTKN | 741 | O75717 | |
| FYDNKGITYLFDLDY | 296 | Q9H5I1 | |
| RAQQLYYYKDEEDTK | 71 | P42331 | |
| YETLEQYGKAYVDYK | 531 | Q07617 | |
| DYRYSQADALKYVGI | 726 | Q92800 | |
| KIFEGGYKSNEEYVY | 1731 | Q5T1R4 | |
| YYNDYGDIIKETLSK | 896 | Q8WVM7 | |
| TKYAYEYDVDGQLQT | 2126 | Q9P273 | |
| DTEEYNLRDYFEKYG | 136 | P51991 | |
| AIAHYEQSADYYKGE | 141 | Q9H115 | |
| YLVENSSKYYEKEAL | 146 | Q2NKQ1 | |
| LKTLAELYTYDKNYG | 511 | P49754 | |
| ELYTYDKNYGNALEI | 516 | P49754 | |
| EYLKYTLDQYVENDY | 56 | P85298 | |
| IGYYDAEKLLEYESL | 491 | Q3C1V9 | |
| GDYEEAIKYYEQYLS | 891 | Q96AY4 | |
| KAYEYDEYGLAYIKQ | 356 | Q8N720 | |
| LNYVEGDYKEALNIY | 106 | Q86TV6 | |
| YLYKAQGVIDDLVYS | 51 | Q96DR4 | |
| KLYQEKDAFQEEYYR | 276 | Q9NRZ5 | |
| ESDYSYYNLILKKAG | 81 | Q9NYU1 | |
| TYLEKIDGFRAYYKQ | 646 | O75127 | |
| GYSYDLEVEQAYDLA | 201 | P28074 | |
| AYSQDAYLKGNEAYS | 176 | Q5T5U3 | |
| YKDVKLTASNDDYYF | 296 | Q8N5T2 | |
| GDYYQLYDKDEDSSE | 416 | O43164 | |
| IFDGGYKSNEEYVYV | 2066 | P15822 | |
| LTKDNPYEYNEYGEI | 291 | Q8NDW4 | |
| YIYEDAYDKLSPENE | 731 | Q15386 | |
| FYSKEYDNEGTVDYS | 2901 | Q15911 | |
| DYDSVDGKVYYTDVF | 1391 | O75096 | |
| YSADYYKANENDAIP | 751 | O15146 | |
| EPLNSYKYDAYKNID | 861 | Q86UW6 | |
| DTSEYIIQAYKYGAF | 576 | Q14CX7 |